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ABSTRACT
DNA is the blueprint of life. It contains all the information necessary for the synthesis of proteins
– the building blocks and workhorses of the cell. Maintenance of DNA in an unchanged state
is therefore of utmost importance, since any mutations or loss of the information it holds may
lead to catastrophic events, such as cell death or tumorigenesis. DNA needs to be faithfully copied
with every cell division, which is an enormous task, given its size and importance. DNA replica-
tion is constantly challenged by endogenous and exogenous factors, which have the potential to
stall or stop replication – such a circumstance is called replication stress. While cells have evolved
a number of mechanisms to deal with replication stress, e.g. checkpoint signaling that halts the
cell cycle, DNA repair pathways that remove obstacles or factors that stabilise stalled replication
forks, persisting replication stress inevitably leads to genomic instability and tumorigenesis. In-
terestingly, cancer cells, due to their unrestricted proliferation, have elevated level of replication
stress, which makes them more susceptible to anti-cancer therapies that exacerbate genomic in-
stability. It is thus obvious that dissecting the events and mechanisms leading to and following
replication stress is important from a basic science and clinical research point of view.
Among the many aspects of replication stress, one that is gaining an increasing amount of at-
tention is replication fork stability. Over the last years it was shown that a stalled replication fork
is rapidly remodeled into a 4-way structure, an event that is believed to contribute to its stabil-
isation. However, such a structure needs to be carefully maintained, since lack of its protection
may cause an unscheduled processing by nucleases, leading to genomic instability. Interestingly,
among the factors that protect stalled replication forks are many proteins previously associated
with other DNA repair pathways, such as homologous recombination or Fanconi anaemia. The
most recent member of the ’protectosome’ group is WRNIP1 (Werner helicase interacting protein
1), but its mode of action is unclear.
In this project, we attempted to characterise WRNIP1’s biochemical activities and investigate
further its cellular function. We have found that the protein exerts its protective function down-
stream of replication fork reversal, challenging the current model. Our in vitro data show that
WRNIP1 binds speciﬁcally to 4-way DNA junctions, a structure resembling a reversed replica-
tion fork. We have also found that WRNIP1 interacts directly with the replication fork remod-
eler ZRANB3 and that it is able to limit its replication fork reversal activity in vitro. Combined
with published data, our data led us to propose a mechanism in which WRNIP1 binds to reversed
replication forks immediately after their generation, thus protecting them against unscheduled
MRE11-dependent degradation.
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ZUSAMMENFASSUNG
DNA ist der Bauplan des Lebens. Sie enthält alle notwendigen Informationen für die Synthese von
Proteinen, den molekularen Werkzeugen der Zelle. Die Integrität der DNA ist äusserst wichtig,
da Mutationen oder der Verlust von Erbinformation katastrophale Folgen, wie Zelltod oder Tu-
morentstehung, haben können. Mit jeder Zellteilung muss die DNA zuverlässig verdoppelt wer-
den, was angesichts der Grösse des Genoms und seiner entscheidenden Bedeutung eine enorme
Herausforderung darstellt. Die Replikation der DNA wird ständig durch endogene oder exogene
Faktoren beeinträchtigt, was dazu führen kann, dass die Replikation blockiert oder abgebrochen
wird. Diesen Zustand bezeichnet man als Replikationsstress. Die Zelle hat verschiedene Mech-
anismen entwickelt, um Replikationsstress entgegenzuwirken; diese umfassen zum Beispiel die
Aktivierung von Checkpoints, die den Zellzyklus anhalten, oder Faktoren, die blockierte Replika-
tionsgabeln stabilisieren. Trotz dieser Schutzmechanismen führt anhaltender Replikationsstress
unausweichlich zu genomischer Instabilität und Tumorigenese. Interessanterweise sind Kreb-
szellen aufgrund ihres unkontrolliertenWachstums inhärent erhöhtenLevels anReplikationsstress
ausgesetzt. Dies macht sie empﬁndlicher gegenüber Krebstherapien, die die genomische Instabil-
ität weiter steigern. Daher ist es oﬀensichtlich, dass die Analyse von Vorgängen, die Replikation-
sstress verursachen sowie entgegenwirken, nicht nur für die Grundlagenforschung, sondern auch
für die klinische Forschung von grosser Bedeutung ist.
Einer der vielen Aspekte von Replikationsstress, der in den letzten Jahren wachsende Beach-
tung bekam, ist die Stabilisation von Replikationsgabeln. Es wurde gezeigt, dass blockierte Rep-
likationsgabeln rasch zu vierarmigen Strukturen umgebaut werden, was vermutlich zu ihrer Sta-
bilisation beiträgt. Jedochmüssen auch diese Strukturen geschütztwerden, um zu vermeiden, dass
sie von Nukleasen prozessiert werden, was wiederum zu genomischer Instabilität führen kann.
Unter den Faktoren, die einen protektiven Eﬀekt auf Replikationsgabeln haben, beﬁnden sich er-
staunlich viele Proteine, die zuvor mit dem DNA-Reparatursystem in Verbindung gebracht wur-
den. Diese umfassen unter anderem Fanconi-Anämie-Enzyme und Proteine, die an der homolo-
gen Rekombination beteiligt sind. Das zuletzt identiﬁzierte Mitglied der sogenannten
’Protektosom’-Gruppe ist WRNIP1 (Werner helicase interacting protein 1), doch seine genaue
Wirkungsweise ist unklar.
Ziel dieses Projektes war es, die biochemischen Aktivitäten von WRNIP1 zu charakterisieren
und seine zelluläre Funktion zu untersuchen. Wir haben festgestellt, dass das Protein seine pro-
tektive Funktion erst nach der Umkehrung der Replikationsgabel ausführt, was ein bestehendes
Modell in Frage stellt. Unsere in vitro-Daten zeigen ausserdem, dass WRNIP1 speziﬁsch an vier-
armige DNA-Strukturen bindet, welche reversierten Replikationsgabeln ähneln. Wir haben auch
eine direkte Interaktion zwischen WRNIP1 und ZRANB3 identiﬁziert und konnten zeigen, dass
ABSTRACT Bartlomiej Porebski
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WRNIP1 in vitro ZRANB3’s Fähigkeit, Replikationsgabeln in vierarmige Strukturen umzubauen,
reduziert. In Kombination mit publizierten Daten deuten unsere Ergebnisse auf einen Mechanis-
mus hin, in dem WRNIP1 direkt nach der Reversierung an Replikationsgabeln bindet und sie so
vor einer MRE11-abhängigen Degradation schützt.
Bartlomiej Porebski ABSTRACT
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1. LIFE CYCLE OF A CELL 1
INTRODUCTION
1 Life cycle of a cell
A cell can be considered the most basic biological entity, due to its ability to perform all the ac-
tivities being hallmarks of life, i.e. metabolism, growth, response to environmental stimuli and,
most importantly, reproduction that ensures survival. All living organisms - from the simplest
prokaryotes to the most complex eukaryotes - are composed of cells, which, despite fundamen-
tal diﬀerences between the two superdomains, follow a similar cycle of growth and reproduction
that involves regulated duplication and equal division of cellular contents, yielding two identical
daughter cells.
1.1 The eukaryotic cell cycle is divided into discrete phases
In contrast to prokaryotic cells, the eukaryotic cell cycle is divided into discrete phases, during
which events, ultimately leading to cell division, happen in a sequential and highly regulated man-
ner (Figure 1). The human cell cycle is generally divided into two main phases: mitosis and inter-
phase, with the former being the moment when the cell physically divides and the latter consisting
Figure 1: Eukaryotic cell cycle (Pines, 2011).
of cell growth and duplication of ge-
netic material. Interphase starts af-
ter a cell has divided or received
a signal that forces it to leave the
quiescent state. In the ﬁrst phase,
G1 (gap 1), the cell grows in size,
synthesizing proteins necessary for
subsequent stages, and, depending
on internal and external cues, either
commits to the cycle or leaves it,
entering aforementioned quiescence
phase (G0).
After G1, which in human so-
matic cells can last up to 11 hours, the
cell enters the S-phase (synthesis) when the blueprint of life – DNA – is replicated, which will be
described in the next section. Cycling human cells allocate around one-third (approximately 8
hours) of the whole cell cycle to complete S-phase. Following is a second, shorter (approx. 4
hours), gap phase (G2) when the cell continues to grow, synthesizes proteins necessary for mitosis
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and ensures that it is ready to divide. In the ﬁnal, shortest (approx. 1 hour) phase (M), the cell
segregates its contents into two pools and undergoes cytokinesis, yielding two identical daughter
cells (Alberts et al., 2002).
Due to its importance and complexity, the cell cycle is strictly regulated by both extra- and
intra-cellular mechanisms. The former, including nutrient availability and the presence of growth
factors, appliesmainly to G1. In cycling cells, nutrients shortage will cause entering quiescent state
when the cell suspends growth until conditions become optimal again. On the other hand, cells
that naturally remain in G0, as is the case for many animal cell types, start cycling only if they
receive an extracellular stimulus forcing them to proliferate, e.g. skin ﬁbroblasts during wound
healing. The intra-cellular mechanism of cell cycle control is built around so-called "checkpoints"
- points during the cell cycle when it can be halted if certain conditions needed to progress to the
next phase are not met. For instance, progression from G1 to S is delayed when DNA is damaged,
progression from G2 to M requires completion of DNA replication, and mitosis is halted when
chromosomes are not properly attached to the mitotic spindle (Alberts et al., 2002).
1.2 Strict regulation of the cell cycle is necessary to avoid unrestricted
proliferation
While cell cycle control mechanisms are not absolutely required for the cell to commit to division,
they are essential to ensure that the process is completed with a positive outcome, e.g. that chro-
mosomes are separated properly, mutations in DNA are not passed on or that a cell does not go
through more rounds of proliferation than it is supposed to. Unsurprisingly, the gene most fre-
quentlymutated in cancers, TP53, encodes a protein which negatively regulates entry into S-phase
and, in case of DNA damage that is beyond repair, triggers apoptosis. Inactivation of p53 allows
cancer cells to replicate DNA that contains lesions, thus propagating genomic instability and lead-
ing to further deregulation of cellular processes. At the same time, loss of p53 function prevents
apoptosis, therefore cancer cells are not eliminated from the population, further committing to
neoplasia (Alberts et al., 2002).
2 DNA Replication
As already mentioned, cells allocate around a third of the cell cycle to replicate DNA. Since DNA
stores the information about, among others, how all the proteins are built, it is of utmost impor-
tance to ensure that the molecule is passed to the daughter cells intact, making DNAmaintenance
processes, like replication and repair, the most crucial ones in the life of a cell.
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2.1 Genome duplication is initiated from replication origins in a highly
regulated manner
While the bulk of DNA synthesis takes place in S-phase, the replication process already starts
in G1 when the pre-replicative complex (pre-RC) is loaded onto the chromatin at certain loci,
Figure 2: Overview of replication initiation (Fragkos et al.,
2015). See text for explanation.
called origins of replication (licens-
ing) (Figure 2). In contrast to
yeast Saccharomyces cerevisiae, fea-
tures marking replication origins
have not been precisely identiﬁed
in metazoans, however there seems
to be a preference for CpG islands
and G-rich regions that can form
G-quadruplexes. Importantly, DNA
replication can only be triggered
from the origins that have been li-
censed, which, when coupled to the
fact that licensing is limited to G1,
provides a very elegant way to avoid
re-replication of the genome. Upon
G1-S transition, additional factors
are loaded to the pre-RC, includ-
ing components of the replicative
helicase CMG (Cdc45-GINS-MCM)
and the replicative polymerases Pol,
Polα and Polδ. Finally, with the en-
try to S-phase, the processivity fac-
tor Proliferating Cell Nuclear Anti-
gen (PCNA) is loadedwith the help of
the Replication Factor C (RFC) com-
plex, to complete the replisome – the
functional unit of replication. Ini-
tiation of DNA synthesis, or origin
ﬁring, also undergoes strict control.
First, only a subset of licensed origins
is activated, the rest is kept dormant
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to serve as a backup, should active replisomes encounter a roadblock. Secondly, to avoid exhaus-
tion of replication factors, not all origins are activated at the same time. It was found that euchro-
matin is being replicated in the early, while transcriptionally inactive heterochromatin in the late,
stage of S-phase. On top of transcription, over the last years, chromatin topology has been recog-
nised as an important determinant of replication origin usage, with chromosomal regions being
in close proximity in space being replicated at the same time. Lastly, the intra-S-phase checkpoint
plays an important role in the regulation of origin ﬁring also during unperturbed replication, as
discussed in the subsequent section (rev. in: Leonard and Méchali (2013), Fragkos et al. (2015)).
2.2 DNA replication is carried out by the replisome at replication forks
At a molecular level, DNA replication is a two-step process, consisting of unwinding of parental
duplex to subsequently use both strands as templates for the synthesis of new ones; both activi-
ties are performed at the replication fork by distinct factors within the replisome in a concerted
manner. The former function is provided by theCMGcomplex, which, upon origin ﬁring, translo-
cates on the parental DNA by virtue of its ATPase activity, prying two strands apart. The resulting
positive supercoiling ahead of the replication fork is resolved by Topoisomerase I, which is in-
dispensable for unhindered replication fork movement. Subsequent DNA synthesis is initiated
by DNA primase (Polymerase Alpha subunit) synthesizing a short RNA primer, which is further
extended by Polα’s DNA polymerase activity. Afterwards, replicative polymerases Polδ and Pol
take over, synthesizing long stretches of DNA with high ﬁdelity, thanks to their processivity and
proofreading capabilities. Due to the chemistry of DNA polymerisation that allows extension of
the primer only at its 3’ end, synthesis of one strand (leading) is continuous, while growth of the
other (lagging) is achieved by repeated cycles of priming and extension, producing short (100-200
nt) Okazaki fragments that are processed and ligated together upon completion by DNA2, FEN1
and DNA Ligase I (rev. in: Branzei and Foiani (2010), Leman and Noguchi (2013)). According to
the consensus view, there is a division of labour between the two replicases, with Pol synthe-
sising the leading and Polδ the lagging strand. However, this view is being challenged over the
last couple of years with studies presenting strong evidence for one polymerase doing the bulk of
DNA replication and the other having an auxiliary role (Georgescu et al. (2014), Yeeles et al. (2015),
Johnson et al. (2015), rev. in Lujan et al. (2016)). Although depictions of the replisome are usually
simpliﬁed to the proteins performing the main enzymatic activities essential for DNA replication,
which is in line with the recently established ’minimal replisome’ (Yeeles et al., 2015), a number
of targeted and unbiased proteomic studies show that the replisome is a far much more complex
assembly consisting of DNA and RNAmetabolising proteins, chromatin remodelers, components
of signaling pathways, etc. (Alabert et al. (2014), Dungrawala et al. (2015), Ribeyre et al. (2016)).
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2.3 DNA replication is challenged by a wide variety of exogenous and
endogenous factors
What has also become evident is that the composition of the replication fork proteome changes in
response to replication stress (Dungrawala et al. (2015), Ribeyre et al. (2016)), a circumstance when
DNA synthesis is stalled or stopped. Replication stress can be caused by pathological conditions,
like unrepaired DNA lesions, reduced dNTPs pools, DNA-protein cross-links or oncogene acti-
vation leading to de-regulation of origin ﬁring, as well as by sources connected to normal cellular
processes and features, such as metabolites, replication-transcription collisions, torsional stress,
diﬃcult-to-replicate sequences, secondary DNA structures or ribonucleotide misincorporation
(Zeman and Cimprich, 2014). The multitude of potential sources suggests that cells are subjected
to replication stress on a daily basis. Under normal conditions, it is eﬃciently dealt with by path-
ways dedicated to DNA damage signaling, repair and cell cycle control (rev. in Ciccia and Elledge
(2010)); as already noted, if damage exceeds repair capacity, the cell may be forced to undergo
apoptosis or enter senescence.
2.4 Replication stress is a potent driver, but also an Achilles heel, of tu-
morigenesis
Aforementioned replication stress response pathways were found to be activated in many precan-
cerous lesions and to act, together with the tumour suppresor protein p53, as a barrier against
tumorigenesis (Figure 3). It was proposed that these benign early lesions progress to malignancy
Figure 3: Model for contribution of replication stress and
genome instability to tumorigenesis (Halazonetis et al., 2008).
when the DNA damage response
pathways or p53 function are com-
promised, exacerbating genomic in-
stability and evading apoptosis
(Bartkova et al. (2005), Halazonetis
et al. (2008)). On the other hand,
counter-intuitively at ﬁrst, cancer
cells are more dependent on DDR
pathways to sustain unrestricted pro-
liferation. This is due to the fact
that, while mild replication stress
is a potent driver of tumorigenesis,
high level leads to cell death by mi-
totic catastrophe, acting as an onco-
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suppresive mechanism. In fact, many anti-cancer therapies, intentionally or not, are based on
aggravating replication stress to levels lethal for cancer cells, yet still tolerable for the healthy
ones. Conventional approaches, like radiotherapy, alkylating agents or platinum-based com-
pounds, introduce DNA lesions, nucleoside analogues reduce the pool of available dNTPs, and
topoisomerases poisons elevate torsional stress - all these have been used as anti-cancer drugs
for years, but only recently were linked to replication stress. Moreover, as our understanding of
this phenomenon progresses, more targeted approaches are under development, for instance se-
lective inhibitors of the ATR-Chk1 signaling cascade that signals replication stress ((Aguilera and
Gómez-González, 2008), Gaillard et al. (2015), Zhang et al. (2016)). All in all, as our knowledge on
the subject expands, it is becoming more evident that replication stress can and should be con-
sidered one of the hallmarks of cancer (Macheret and Halazonetis (2015), Hanahan and Weinberg
(2011)).
3 Replication stress response
3.1 ATR initiates the cellular response to replication stress
3.1.1 Activation of ATR signaling cascade at stalled replication forks
The replication stress response may be considered a speciﬁc sub-pathway of the DNA damage
response. It is not triggered directly by lesions, but is rather a consequence of the replication fork
encountering an obstacle. Such an event causes fork stalling and leads to the generation of long
stretches of ssDNA that, when coated with the ssDNA-binding protein RPA (Replication Protein
A), contributes to the activation of ATR (Ataxia telangectasia and Rad3-related) – the kinase that
orchestrates the replication stress response (Figure 4) (rev. in Saldivar et al. (2017)). Excess ssDNA
can stem from functional uncoupling of the helicase and polymerase functions of the replisome
(Byun et al., 2005). A second requirement for an eﬃcient ATR activation is a 5’-ended ssDNA-
dsDNA junction, arising either naturally on the lagging strand due to repeated priming or as a
result of re-priming on the leading strand template e.g. by PrimPol (Mourón et al., 2013). Both
of these structures can be also formed by stalled fork remodeling and processing, which will be
described in subsequent sections. Important components necessary for triggering theATR cascade
are early activating factors: ATRIP (ATR-interacting protein), TOPBP1 (Topoisomerase II binding
protein 1) and ETAA1 (Ewing tumour-associated antigen 1), which facilitate ATR recruitment to
the ssDNA-RPA and engage its kinase activity (rev. in Saldivar et al. (2017)).
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3.1.2 ATR-CHK1 cascade suppresses cell cycle progression and origin ﬁring in response
to replication stress
Two key eﬀects of ATR - cell cycle arrest and suppression of late origin ﬁring - are mediated
via phosphorylation of its substrate, CHK1 (Checkpoint Kinase 1) (rev. in Saldivar et al. (2017)).
While cell cycle arrest is presumed to simply prevent entry into mitosis with damaged or under-
replicated DNA, ATR’s role in origin ﬁring regulation is more complex. Of note, ATR-CHK1
pathway prevents excessive origin ﬁring in an unperturbed S-phase, presumably to ensure that
the amount of active replisomes does not exceed the supply of replication factors. Indeed, it was
shown that forcing unscheduled origin ﬁring by ATR inhibition causes global fork breakage even
in unchallenged cells and is exacerbated by the induction of replication stress; it was attributed
to the exhaustion of RPA when too many replisomes are active at the same time (Toledo et al.,
2014). On the other hand, the ATR pathway is believed to activate dormant origins in the vicinity
of stalled replication forks to complete replication. While the mechanism of this local activation
is enigmatic, it is suspected that all origins within a chromatin region that is being replicated are
immune to inhibition by the checkpoint (rev. in Saldivar et al. (2017)).
3.1.3 ATR stabilises stalled replication forks by preventing RPA exhaustion and regu-
lating fork-associated proteins
Another important role of ATR in the replication stress response is to stabilise the stalled replica-
tion fork, i.e. to ensure that the replisome is able to resume replicationwhen the stress is dealt with,
by preventing detrimental processing and promoting restart eﬀorts. One way ATR achieves this is
via the aforementioned inhibition of late origin ﬁring, which prevents exhaustion of the cellular
pool of RPA, a protein that when bound to ssDNA serves as a recruitment platform for many DDR
proteins (Toledo et al., 2014). It is also plausible that excessive origin ﬁring might deplete other
factors necessary for stalled fork stabilisation. Also, ATRmay exert its protective function by reg-
ulating enzymes that process stalled replication forks. Indeed ATR was shown to phosphorylate
several replication fork remodelers, such as SMARCAL1 (SWI/SNF-related, matrix-associated,
actin-dependent regulator of chromatin, subfamily-A-like 1) (Couch et al., 2013), WRN (Werner
syndrome helicase) and BLM (Bloom syndrome helicase) (rev. in Urban et al. (2017)). It was shown
that hyperactivation of SMARCAL1 caused by ATR-inhibition, may cause generation of SLX4
(Structure-speciﬁc endonuclease subunit SLX4)-dependent DNA breaks, suggesting that remod-
eling of stalled replication forks has to be strictly controlled (Couch et al., 2013). Importantly, while
it was believed that fork breakage is associated with disassembly of the replisome, proteome-wide
study using iPOND-SILAC (Isolation of Proteins on Nascent DNA-Stable Isotope Labeling with
Amino Acids in Cell Culture) mass spectrometry showed that the core replisome proteins remain
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Figure 4: Proposed eﬀects of ATR-mediated signaling in the replication stress response (Saldivar et al.,
2017).
stably bound at stalled replication forks (Dungrawala et al., 2015). The same study also provided
quantitative data about the proteome of stalled replication forks, strengthening the involvement
of many proteins, conventionally linked to canonical DNA repair pathways, in the events at stalled
replication forks. Interestingly, many of these factors are known ATR substrates (rev. in Toledo
et al. (2017)).
3.2 PCNA orchestrates events at replication forks
A second important event that senses and signals replication stress is the modiﬁcation of PCNA,
inducedwhen the replisome is stalled. PCNA is one of themain conductors of events at the replica-
tion fork. In unperturbed conditions, it stimulates processivity of replicative polymerases and acts
as an interaction hub for enzymes processing Okazaki fragments (rev. in Moldovan et al. (2007));
all PCNA-interacting proteins have conserved binding motifs, with the PIP (PCNA-interacting
protein)-box being the most common one.
3.2.1 Modiﬁcation of PCNAbyubiquitin is decisive for replication stress response path-
way choice
Besides its function in replication, PCNA coordinates the replication stress response at a stalled
replisome, in a modiﬁcation-dependent manner. Upon replication fork stalling, PCNA is either
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mono-ubiquitylated at the conserved lysine 164 (K164) by Rad6/Rad18 (S. cerevisiae E2 ubiquitin-
conjugating enzyme and E3 ubiquitin ligase, respectively) or poly-ubiquitylated by
Rad5/Ubc13-Mms2 (S. cerevisiaeE3 andE2, respectively), forming lysine-63-linked poly-Ub chains.
In general, the ubiquitylation of PCNA triggers a DNA damage tolerance pathway, which, as the
name suggests, allows replication to pass the lesion, without prior repair. The type of PCNA
modiﬁcation dictates the choice of subpathway. Mono-Ub recruits translesion synthesis (TLS)
polymerases that are able to accommodate the damaged base in their catalytic centre and insert
a nucleotide opposite. Frequently, the inserted nucleotide is incorrect, therefore TLS pathway is
considered error-prone. On the other hand, poly-ubiquitylation of PCNA triggers an error-free
pathway; it is thought to involve template switching or recombination-mediated replication, but
the exact mechanism is still unknown. It is often suggested that replication fork reversal may be
one of the transactions mediating it (rev. in Moldovan et al. (2007), Mailand et al. (2013)). While
in yeast, poly-ubiquitylation of PCNA and its eﬀects are well established, research in human cells
proved to be more challenging. To induce and sustain the modiﬁcation, acute genotoxic treat-
ments or speciﬁc genetic conditions are required (Brun et al. (2010), Ciccia et al. (2012)). More-
over, there are two human homologues of Rad5 - HLTF (Helicase-like transcription factor) and
SHPRH (SNF2 histone linker PHD ring helicase) (Motegi et al., 2008); the choice of the E3 ligase
seems to be dependent on the type of DNA lesion (Lin et al., 2011). Recently, a third ubiquitin lig-
ase able tomodify PCNAwas detected –TRAIP (TRAF interacting protein) (Hoﬀmann et al., 2016).
3.2.2 PCNA SUMOylation regulates recombination at replication forks
Apart from ubiquitylation, PCNA can be also modiﬁed by SUMO (Small ubiquitin-like modiﬁer)
at the same residue – Lys164. The majority of discoveries on this subject were made in yeast,
where SUMOylation of PCNA is well established, in contrast to human cells. In yeast, a portion of
PCNA was found to be constitutively SUMOylated during the S-phase. The modiﬁcation serves
as a recruitment platform for SUMO-PCNA readers that have a SIM (SUMO-interacting motif)
domain, such as Srs2 – a helicase that prevents unscheduled recombination by destabilising Rad51
nucleoﬁlaments (rev. in Mailand et al. (2013)). Several human orthologues of Srs2 have been pro-
posed based on their ability to disrupt RAD51-ssDNA complexes, e.g. RTEL1 (Barber et al., 2008),
FBH1 (F-box DNA helicase 1) (Fugger et al., 2009), however only one of them – PARI (PCNA-
interacting partner) – was shown to bind SUMO-PCNA (Moldovan et al., 2012). It has to be noted
though, that SUMOylation of PCNA in human cells cannot be detected unless a tagged ectopic
allele of SUMO is overexpressed (Gali et al., 2012), rendering the presence of such a modiﬁcation
on human PCNA a subject of ongoing debate.
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4 Transactions at stalled replication forks
4.1 Importance of stalled fork stabilisation
Ensuring the stability of a stalled replication fork is of great importance, since failure to do so
results in replication fork breakage, or collapse. Fork collapse is deﬁned as a loss of capacity
to perform DNA synthesis; such a general deﬁnition allows accommodating multiple proposed
events leading to the collapse, e.g. replisome disassembly or nucleolytic degradation. Irrespective
of the cause, fork collapse can lead to incomplete or aberrant DNA replication, whichmay result in
the loss of genetic information, chromosomal aberrations, aneuploidy, etc. Thus, replication fork
collapse can be considered as the molecular event underlying genomic instability, emphasising
the importance of fork stabilisation (Zeman and Cimprich (2014), Cortez (2015), Gaillard et al.
(2015)).
Figure 5: A general overview of possible transactions at replication forks following genotoxic stress. Stalled
replicaiton fork regression into a 4-way structuremay prevent fork collapse (loss of replicative potential) or
fork breakage (DSB formation at a fork) and enable restoration of an active replication forkwhen replication
stress subsides. Modiﬁed from (Neelsen and Lopes, 2015).
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4.2 Replication fork reversal is an early response to replication stress
In order to avoid replication fork breakage, it is intuitive to imagine that response mechanisms
should be in place that would enable recruitment of canonical DNA repair factors and allow them
to process the lesion, while, at the same time, provide a way to restart the fork, after the damage
is repaired, or to by-pass the lesion. One such mechanism was proposed in 1976; it assumed re-
modeling of the fork stalled by a single-strand lesion into a four-way junction by fork reversal,
which would cause the two nascent strands to anneal. Such a transaction would create an alter-
native template for the stalled strand, therefore allowing replication without the need to remove
the lesion (Higgins et al., 1976). In another scenario, fork reversal could facilitate the repair of the
damage by relocating it back into the dsDNA region, which could make it more accessible to DNA
repair enzymes. Despite being an appealing idea, it was subsequently discredited due to tech-
nical concerns. Two decades later, a study in Escherichia coli showed that replication-associated
double-strand breaks are dependent on the activity of the RuvAB complex, which is able to gen-
erate four-way junctions (Holliday junctions) by means of its branch migration activity, reviving
the idea of stalled fork reversal (Seigneur et al., 1998). Several years afterwards, studies in S. cere-
visiae showed that replication stalling with hydroxyurea (HU) in checkpoint-deﬁcient cells causes
accumulation of four-way replication intermediates (Lopes et al., 2001). The intermediates were
further identiﬁed as reversed forks with the use of electron microscopy (Sogo et al., 2002).
Interestingly, while fork reversal observed in bacteria was thought to be a way to avoid exces-
sive fork breakage and ensure fork restart (rev. inMichel and Sandler (2017)), evidence from yeast
suggested that the regressed fork is a pathological structure that only occurs when the replication
checkpoint is defective (Lopes et al. (2001), Sogo et al. (2002)). Over the next ten years, multiple
studies showed that fork reversal could be catalysed by several enzymes in vitro (rev. in Neelsen
and Lopes (2015) and see below). The ﬁrst evidence for replication fork reversal in human cells
came in 2012, when it was reported that mild Topoisomerase I inhibition by CPT (camptothecin)
causes fork regression in a PARP1 (Poly [ADP-Ribose] Polymerase 1)-dependent manner. The fact
that this remodeling event was necessary to limit CPT-induced double-strand breaks was a strong
argument in favour of replication fork reversal being a protective, rather than a deleterious event
(Ray Chaudhuri et al., 2012). Further work from the same lab has shown that replication forks
are regressed also in response to oncogene over-expression (Neelsen et al., 2013), on repetitive
sequences (Follonier et al., 2013) and, ﬁnally, by induction of replication stress with several com-
monly used genotoxins (Zellweger et al., 2015). Moreover, in the cited studies, a small amount
of regressed forks was reproducibly found in unchallenged cells. All these data strongly suggest
that replication fork reversal is a general response to replication stress and is needed to prevent
replication fork collapse (Figure 5).
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Figure 6: A general view on formation and processing of reversed replication forks (Neelsen and Lopes,
2015). See text for explanation
4.3 Factors involved in replication fork remodeling
The mechanism of stalled fork reversal is still a subject of research and discussion, however early
work in bacteria suggests an involvement of homologous recombination (HR) factors, conven-
tionally thought to act exclusively in double-strand break repair (Seigneur et al., 1998). In this
study, the authors concluded that HR proteins act on a RuvAB-reversed fork to protect it from
nucleolytic cleavage and assist replication restart. Further studies in human cells implicate more
homologous recombination proteins, such as RAD51 (Hashimoto et al. (2010), Petermann et al.
(2010)), BRCA2 (Lomonosov et al. (2003), Schlacher et al. (2011)), BRCA1 (Schlacher et al., 2012)
and MRE11 (Hashimoto et al. (2010), Schlacher et al. (2011), Schlacher et al. (2012)), in the events
at a stalled replication fork. Also, recent data shows that polyubiquitylation of PCNA that initiates
the recombination-dependent PRR pathway, as described earlier, is necessary for replication fork
reversal in human cells (Vujanovic et al., 2017).
4.3.1 RAD51 is a central node in replication fork reversal
The exact molecular events leading to replication fork reversal are yet to be elucidated, but RAD51
seems to play a central role in the process. It was found to be indispensable for replication fork
reversal induced by a panel of genotoxins in human U2OS cells (Zellweger et al., 2015). RNAi-
mediated depletion of RAD51 completely abrogated replication fork reversal, directly assayed by
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electron microscopy, along with reverting other phenotypical features associated with the rever-
sal: slowdown of replication fork progression, ssDNA accumulation at the stalled fork and a lack
of double-strand breaks induction. Since RAD51 associates with replication forks even in unper-
turbed conditions (Zellweger et al., 2015), its activity has to be controlled to avoid unscheduled
recombination. Recently, RADX (RPA-related, RAD51-antagonist on X-chromosome), a ssDNA-
and RAD51-binding protein, was shown to limit RAD51’s recruitment to replication forks, thus
limiting remodeling events (Dungrawala et al., 2017).
4.3.2 ATPases mediating replication fork reversal in vitro and in cells
Apart from RAD51, a number of enzymes were suggested to mediate replication fork remodeling
(rev. in Neelsen and Lopes (2015)). All these enzymes use the energy from ATP hydrolysis to
either ﬁrst unwind and then anneal DNA strands (canonical helicases) or migrate the branch point
(translocases).
DNAhelicases So far, 5 helicases able to remodel fork-like structures were identiﬁed in human
cells: the RECQ helicases BLM,WRN, RECQL5 (RECQ-like helicase 5) (rev. in Urban et al. (2017))
and RECQL1 (Berti et al., 2013) and FBH1 (Fugger et al., 2015).
RECQ helicases Among these, the best studied are BLM and WRN. While in vitro, both
proteins can mediate fork regression, as well as fork restoration reactions, their functions in cells
are not clear. Both are recruited to replication forks under stress conditions, where they are targets
for ATR-dependent phosphorylation. Apart from being a target, WRNwas also found to promote
activation of the ATR cascade. Cells lacking or expressing amutant allele ofWRN are highly sensi-
tive to replication-stress-inducing agents, have impaired replication fork restoration and elevated
frequency of replication fork reversal (rev. in Urban et al. (2017)). All these phenotypes could be
explained with data suggesting that WRN co-operates with DNA2 in the controlled resection of
reversed replication forks to facilitate their restart (Thangavel et al., 2015). Reports about BLM
helicase suggest that it may be involved in the control of RAD51-mediated recombination at the
fork - on the one hand the two proteins co-operate in the restoration of replication forks, but on
the other, Bloom-syndrome-patient-derived cells have an elevated frequency of sister chromatid
exchanges (SCEs), which are thought to result from unrestricted recombination events (rev. in
Urban et al. (2017)).
The third member of the human RECQ family, RECQ5, is also able to regress replication-
fork-like structures in vitro (rev. in Neelsen and Lopes (2015)). The cellular function of RECQ5
is not clear, however existing evidence shows that it is involved in the prevention or resolution of
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replication intermediates that arise from transcription-replication collisions (rev. in Urban et al.
(2017)).
FBH1 FBH1, one of the putative functional homologues of yeast Srs2, FBH1 was initially
identiﬁed as a suppressor of RAD51-mediated recombination following replication stress, by dis-
placing RAD51 from chromatin in a helicase-activity-dependent fashion (Fugger et al. (2009),
Simandlova et al. (2013)). Moreover, FBH1 can directly ubiquitylate RAD51, which prevents its
association with DNA (Chu et al. (2015)). FBH1 also co-operates with MUS81 in the generation
of DSBs after prolonged replication fork stalling, which triggers apoptosis, thus eliminating cells
with high levels of genomic instability (Fugger et al., 2013). On the other hand, FBH1 has been later
shown to mediate replication fork reversal, both in vitro and, as the ﬁrst human enzyme, in cells
(Fugger et al., 2015). Nonetheless, these somewhat contradictory data can be explained by a model
where FBH1 does promote replication fork regression immediately after fork stalling, however,
if the fork is not recovered within a certain time, FBH1 displaces RAD51 from the reversed fork,
which enables MUS81-dependent DSB formation. Indeed, the duration of genotoxic treatments
used in the cited studies supports this hypothesis, demonstrating howdynamic the events at stalled
replication forks are and underscoring the necessity for a careful experimental design.
DNA translocases Apart from DNA helicases, several dsDNA translocases were proposed as
good candidates for mediating replication fork reversal (rev. in Neelsen and Lopes (2015), Poole
and Cortez (2017)). These enzymes recognise the branch point of a fork and are able to migrate it,
so that the parental strands are wound back and the nascent ones annealed together, forming the
regressed arm. So far, ﬁve dsDNA translocases have been implicated in replication fork reversal
– RAD54 (DNA repair and recombination protein RAD54), FANCM (Fanconi anaemia group M
protein), SMARCAL1, ZRANB3 (Zinc ﬁnger, RAN-binding domain containing 3) and HLTF.
RAD54 RAD54 activities have been analysed mainly in vitro, where it was identiﬁed as a
dsDNA translocase that is able to perform branch migration of 3- and 4-way junctions, with a
preference for fork reversal over restoration. Additionally, RAD54 interacts with RAD51 and
promotes its association with DNA. Even though biochemical activities of RAD54 make it a per-
fect candidate for mediating fork reversal, there is no data from experiments in cells that would
support this hypothesis (rev. in Mazin et al. (2010)).
FANCM The Fanconi anaemia translocase FANCM was shown to drive replication fork
reversal in vitro (Gari et al., 2008b), maintain replication in cells in an ATP-dependent manner
(Blackford et al., 2012) and activate ATR signaling upon replication stress (Collis et al., 2008). Also,
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recent data suggest a role of FANCM at the replisome stalled by an ICL, where the protein is
suspected to drive fork regression that would facilitate either ICL repair or its traverse (Walter
lab, unpublished, Mutreja and Lopes, unpublished).
HLTF, SMARCAL1, ZRANB3 The next two translocases - SMARCAL1 and ZRANB3 -
were identiﬁed as the ﬁrst enzymes that are able to rewind complementary DNA strands and were
termed "annealing helicases" (Yusufzai andKadonaga (2008), Yusufzai andKadonaga (2010)). It was
then shown that the proteins use this activity to mediate branch migration reactions in vitro, in
a similar way to HLTF. All three enzymes can catalyse fork regression, as well as fork restoration
reactions, albeit the former seems to be the preferable one in vitro (Bétous et al. (2012), Blastyak
et al. (2010)). All three enzymes were implicated in replication fork reversal in cells by the use
of electron microscopy or DNA ﬁbres (Kile et al. (2015), Vujanovic et al. (2017), Taglialatela et al.
(2017)).
Interestingly, while the enzymatic activities were assayed in the same way and rely on ATP
hydrolysis, the three proteins seem to use diﬀerent conserved structural features to facilitate DNA
binding and mediate the reaction. SMARCAL1 uses a HARP (HepA-related protein) domain to
recognise branched DNA containing both dsDNA and ssDNA (Bétous et al., 2012). HLTF has a
preference for branched DNA substrates and depends on its HIRAN domain’s (HIP116 Rad5p N-
terminal) ability to bind a 3’OH-ended DNA. In contrast to the other two, the 3D-structure of
ZRANB3 has not been determined yet, however it was recently shown that its HARP-like domain
is necessary for DNA binding and its ATPase and branchmigration activities (Badu-Nkansah et al.,
2016). Such diﬀerent ways of binding seemingly the same substrate may confer speciﬁcity to these
enzymes for a particular structure that arises at a blocked replication fork, e.g. HLTFmay act when
the tip of the leading strand is in close proximity to the branch point, while SMARCAL1 can re-
verse the fork if there is an accumulation of ssDNA on both template strands. In addition to fork
remodeling, all three enzymes are able to metabolise D-loops and ZRANB3 possesses a unique
ATP-dependent endonuclease activity, however its role remains unclear (Weston et al., 2012).
At a cellular level, all three proteins are involved in the replication stress response, since their
depletion causes typical phenotypes, such as altered replication dynamics under stress, defects in
replication restart, replication-associatedDNAbreaks and a sensitivity to genotoxins (rev. in Poole
and Cortez (2017)). Importantly, some of these phenotypes are non-overlapping, suggesting non-
redundancy of the enzymes. This is further supported by the fact that co-depletion of ZRANB3
and SMARCAL1 sensitises cells to genotoxins more than individual knockdowns (Ciccia et al.,
2012). Also the way cells regulate the activity of these enzymes diﬀers signiﬁcantly. SMARCAL1
was shown to be recruited to replication sites by an interaction with RPA (Yusufzai et al. (2009),
Bansbach et al. (2009)), which is enhanced upon HU-treatment (Bétous et al., 2012). RPA also reg-
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ulates SMARCAL1 branch migration activity in vitro by providing a preference for forks with a
leading-strand gap, which reﬂects a pathological situation, in contrast to a physiological lagging-
strand gap (Bétous et al., 2013). SMARCAL1’s branchmigration activity is also negatively regulated
by stress-induced phosphorylation mediated by ATR, ATM and DNA-PKcs (DNA protein kinase,
catalytic subunit). Phosphorylation is necessary to avoid replication fork collapse, demonstrating
that fork reversal, while needed for stalled fork stabilisation, has to be kept under a strict control
to avoid genomic instability (Couch et al., 2013). In contrast to SMARCAL1, ZRANB3 does not
interact with RPA (Yusufzai and Kadonaga, 2010), but is rather recruited to the stalled forks by
modiﬁed PCNA. ZRANB3 contains two motifs that mediate interaction with unmodiﬁed PCNA
– the PIP box and APIM (AlkB homolog 2 PCNA-interaction motif) – and an NZF (Npl4 zinc ﬁn-
ger) motif that binds to poly-ubiquitylated PCNA; all three domains are necessary for the eﬃcient
recruitment of ZRANB3 to foci after DNA damage (Ciccia et al., 2012) and for mediating fork
reversal in cells (Vujanovic et al., 2017). Although not much is known about any post-translational
modiﬁcations, inhibition of DDR kinases by caﬀeine prolongs ZRANB3’s retention in DNA dam-
age foci, suggesting a potential regulatory mechanism similar to SMARCAL1 (Ciccia et al., 2012).
HLTF shares the architecture and activitieswith its better-investigated yeast homologue, Rad5.
Both proteins have a RING (Really Interesting New Gene) domain, which confers the ubiquitin
E3 ligase activity that mediates poly-ubiquitylation of PCNA upon replication stress (Motegi et al.,
2008); this modiﬁcation is thought to trigger an error-free, recombination-based pathway to sta-
bilise or restart replication forks. HLTF possesses an ATP-dependent dsDNA translocase activity
that drives branch migration. Depletion of HLTF sensitises the cells to genotoxins (Motegi et al.,
2008) and changes replication dynamics under stress conditions, which was attributed to the lack
of protective fork reversal catalysed by HLTF (Kile et al., 2015). Regulation of the protein’s activity
or its cellular behaviour have remained unclear.
Several recent reports suggest that SMARCAL1, ZRANB3 and HLTF comprise the trio that is
solely responsible for replication fork reversal upon HU treatment in BRAC1/2-deﬁcient back-
ground and each of them is equally important for the process. The studies also suggest that the
regressed replication fork, if left unprotected, is an entry point for detrimental nucleolytic over-
processing (Mijic et al. (2017), Lemaçon et al. (2017), Taglialatela et al. (2017), Kolinjivadi et al.
(2017)).
4.4 Replication fork restart
There are several proposed models for the restart of replication forks stalled by conditions that
do not modify the template strand, such as hydroxyurea or aphidicolin (Petermann and Helleday
(2010), Berti and Vindigni (2016)). Since RAD51 was found to be necessary for stalled replication
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forks restart, both with and without the generation of double-strand breaks (Petermann et al.,
2010), the above-mentioned models predict recombination reactions to be involved. Indeed, the
ﬁrst report on the mechanism of replication fork restart in vivo shows that upon mild topoiso-
merase inhibition, RECQ1 helicase (a.k.a. RECQL1 - RECQ-like helicase 1) restarts replication by
converting a 4-way junction into a 3-way one. The activity of RECQ1 is controlled by PARP1-
mediated PARylation – upon replication stress PARP1 modiﬁes the helicase, thereby inhibiting
its fork restart activity and stabilising the fork in the regressed state (Berti et al., 2013). In the
second model, the regressed arm is processed to generate a 3’-tail, which is then used for the
RAD51-mediated strand invasion downstream of the branch point. Indeed, recent results suggest
that nucleolytic processing of the reversed fork by DNA2 (DNA replication ATP-dependent heli-
case/nuclease) is needed for eﬃcient replication restart (Thangavel et al., 2015). The two studies
were done using short genotoxic treatment, however long lasting replication fork stallingwas pro-
posed to elicit replication restart pathways that are mediated via a transient double-strand break,
generated at the fork byMUS81 endonuclease (Hanada et al. (2007), Pepe andWest (2014)). Subse-
quently, replication may be restarted via RAD51-mediated HR-like strand invasion downstream
of the branch point, followed either by resolution of the resulting D-loop to restore functional
a replication fork or by break-induced replication (Petermann and Helleday, 2010). Recent stud-
ies conﬁrmed the latter hypothesis, showing that in lack of adequate protection, even short fork
stalling may lead to MUS81-mediated cleavage of the fork and initiation of break-induced repli-
cation. However, such a fork restart pathway ultimately leads to genomic instability, suggesting
that resuming replication via DSB formation is a last resort mechanism to complete genome du-
plication if safer measures fail (Lemaçon et al., 2017).
4.5 Open questions regarding replication fork remodeling
Fate of the replisome
Among the many open questions regarding the mechanism of stalled fork reversal is what hap-
pens with the replisome during this transaction. The replisome is a multi-protein assembly, with
many proteins physically bound to newly synthesised, template or both DNA strands. It is dif-
ﬁcult to imagine a scenario in which all these proteins stay bound, while the parental stands are
being wound back and nascent ones annealed and extruded from the branch-point. On the other
hand, recent iPOND data suggest that the abundance of the core replisome components does not
decrease upon replication fork stalling with hydroxyurea (Dungrawala et al., 2015). A simple so-
lution to these contradicting ideas would be the existence of factors that displaces replisome pro-
teins from DNA, while being retained at the reversed replication fork, ready to help re-assemble
a functional replisome when replication has to be restarted. In 2012, such a process was observed
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in vitro for T4 bacteriophage UvsW (Ultraviolet sensitive W) helicase, which was able to reverse a
stalled replication fork, shift the replisome proteins to the regressed arm and then help restore a
functional replication fork (Manosas et al., 2012).
Signaling events in the response to replication fork reversal
Another facet of replication fork reversal that is being debated, is whether or not it involves any
signaling cascade. Given the requirement of extensive ssDNA at the fork, it can be assumed that
canonical ATR signaling precedes the reversal. However, the question if the 4-way junction elicits
a distinct response is open. One study suggests that replication fork reversal mediated by the he-
licase FBH1 initiated DSB signaling that involves ATM (Ataxia telengectasia mutated)-dependent
phosphorylation of CHK2 (Checkpoint kinase 2) and RPA (Fugger et al., 2015). It could be ex-
plained by the fact that the regressed arm is essentially a one-ended double strand break. These
results were then challenged by a study analysing replication fork reversal in response to a panel of
genotoxins; although all compounds caused ssDNA accumulation and fork reversal, activation of
ATM and ATR signaling cascades diﬀered greatly. Importantly, none of the analysed drugs caused
the previously reported phosphorylation of CHK2 and RPA (Zellweger et al., 2015).
4.6 Potential roles of replication fork reversal
In the original model, fork reversal was envisioned as a way to assist repair or bypass of the
template-strand lesion (Higgins et al., 1976). Although the mechanistic role of fork regression
is still lacking, it is undoubtedly more complex than initially proposed. First of all, among com-
pounds that elicit fork reversal are hydroxyurea and aphidicolin (Zellweger et al., 2015), which
modes of action do not generate physical lesions, but rather prevent DNA synthesis by limiting
the pool of available deoxyribonucleotides and inhibiting the replicative polymerases, respectively.
A possible role for replication fork reversal in these conditions would be to limit the functional
uncoupling of helicase and polymerases, thus preventing accumulation of ssDNA at the stalled
fork. Fork reversal can be also triggered by reagents that induce inter-strand crosslinks (ICL),
such as cisplatin and mitomycin C (Zellweger et al., 2015). The potential role of fork regression
in response to ICL is even more elusive, since there is no consensus on how cells deal with these
lesions. One model suggests that ICLs are absolute roadblocks for the replisome and their repair
requires two incoming replication forks to converge on both sides of an ICL (Zhang et al., 2015);
after the convergence, CMG helicase is evicted by VCP (Valosin-containing protein, a.k.a. p97)
from one of the forks, which triggers its reversal by FANCM (Fanconi anemia complementation
groupM) (Walter lab, unpublished). The role for fork reversal in this contextwas not discussed, but
it can be speculated that moving the branch-point away from the ICL by rewinding the parental
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duplex could facilitate repair of the lesion. A diﬀerent model suggests that, in themajority of cases,
the replisome does not stop at the ICL, but rather is able to traverse it in a FANCM-dependent
manner, without the necessity for convergence (Huang et al., 2013). Interestingly, replication forks
encountering and traversing ICLs (local forks) are not reversed, in contrast to distal ones (global
forks) (Mutreja and Lopes, unpublished). A possible explanation for these data is that the progres-
sion of global forks has to be halted to give the local ones enough time to traverse; otherwise, the
supercoiling generated by an incoming fork could hinder the eﬃcient traverse (Mutreja, personal
communication).
Apart from the potential positive eﬀects, stalled fork regression can also contribute to - rather
than prevent - genomic instability, for instance by causing expansion of tri-nucleotide repeats
(Follonier et al., 2013). Also, a four way junction formed by the regression could be a perfect sub-
strate for structure-speciﬁc nucleases, like MUS81 (Methyl methanesulfonate and UV-sensitive
clone 81), what will be elaborated on in the subsequent section.
4.7 Nucleolytic processing of stalled replication forks
The importance of stalled replication fork stabilisation to avoid genomic instability is very well
established. However, still very little is known about the events taking place directly at the stalled
fork that ensure its protection against collapse. Over the last several years, the idea of a ’protec-
tosome’ emerged, referring to a group of proteins that protect the stalled replication fork from
unscheduled nucleolytic degradation by nucleases conventionally connected to DSB repair by ho-
mologous recombination (Figure 7) (rev. in Higgs and Stewart (2016)). Among these proteins
there are several factors belonging to the HR or Fanconi anaemia repair pathways, such as RAD51
(Hashimoto et al., 2010), BRCA1/2 (Schlacher et al. (2011), Schlacher et al. (2012)), REV1 (Yang
et al., 2015), FANCD2 (Schlacher et al., 2012) and BOD1L (Higgs et al., 2015). All these were found
to protect the nascent DNA at replication forks from degradation mediated by MRE11 or DNA2
under mild replication stress conditions that do not generate DSBs. The exact protective mech-
anism is not known for any of them, but all seem to be important for RAD51 stabilisation at the
fork, and failure to do so leads to nascentDNAdegradation and ensuing chromosomal aberrations.
The importance of dissecting the stalled replication fork stabilisation pathway was recently un-
derscored by the ﬁnding that restoration of stalled fork protection is one way BRCA1/2-deﬁcient
tumours can acquire resistance towards the PARP1 inhibitor Olaparib (Chaudhuri et al., 2016).
As noted, the mechanistic insights into stalled fork protection and degradation are largely
unknown. It was originally speculated that a reversed replication fork could be the structure tar-
geted by the nucleases (Schlacher et al., 2011), which was further supported by ﬁndings suggesting
that, upon mild replication stress, stalled forks are immediately regressed in a RAD51-dependent
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fashion (Zellweger et al., 2015). Indeed, recently, several groups found that, at least in BRCA1/2-
deﬁcient background, RAD51-, ZRANB3-, SMARCAL1- or HLTF-mediated replication fork re-
versal is necessary for the unscheduledMRE11-dependent degradation to occur (Mijic et al. (2017),
Lemaçon et al. (2017), Taglialatela et al. (2017), Kolinjivadi et al. (2017)). However, although RAD51
is indispensable for replication fork regression, this step is diﬀerent than loading of the recombi-
nase during HR since it does not depend on BRCA2 (Mijic et al., 2017). In contrast, the resection
of an unprotected fork was found to follow the same process as in the canonical HR (rev. in Cejka
(2015)), i.e. nascent DNA degradation is initiated by CtIP (CtBP-interacting protein) together with
MRE11 and then continued by a more potent exonuclease, EXO1 (Exonuclease 1) (Lemaçon et al.,
2017). In agreement with a number of reports unequivocally stating that unscheduled nascent
Figure 7: The importance of stalled replication fork protection for
ensuring genomic stability (Higgs and Stewart, 2016).
DNA resection is deleterious to
the cell (rev. in Higgs and Stew-
art (2016)), fork degradation
was found to cause an elevated
number of chromosomal aber-
rations (Lemaçon et al. (2017),
Mijic et al. (2017), Taglialatela
et al. (2017)). However, a
surprising discrepancy was re-
ported with regard to fork re-
versal - one of the studies shows
that preventing resection by
blocking fork reversal exacer-
bates genomic instability (Mijic
et al., 2017), while the other re-
ports an alleviation (Taglialatela
et al., 2017). While this dif-
ference is diﬃcult to reconcile,
the necessity of proper main-
tenance of stalled replication
forks is obvious and may ex-
plain the growing number of factors found required for this process. Apart from the already listed
HR/FA-pathway components, very recently WRNIP1 (Werner helicase interacting protein 1) –
a protein of uncharacterised activity was found to co-operate with BRCA2 in the protection of
stalled replication forks from MRE11-dependent degradation (Leuzzi et al., 2016) (Figure 8A).
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5 WRNIP1
WRNIP1 was identiﬁed in 2001 as an interactor of WRN in a yeast two-hybrid screen and in vitro
pull-down experiments (Kawabe et al., 2001). The protein is ubiquitously and evenly expressed
in human tissues, with some databases reporting an elevated abundance in the brain (The Human
Protein Atlas). There are two transcript variants of WRNIP1 present in cells, resulting from an
alternative splicing event – putatively activation of an alternative 3’ splice site in exon 3, which
produces a protein that has an internal truncation of 25 amino acids. Genome-wide mRNA se-
quencing data show that the shorter transcript is present at very low levels, both in healthy and
cancerous tissues (0-5% of total WRNIP1 transcripts) (ISOexpresso database).
5.1 Structural features of WRNIP1
WRNIP1 homologues are found from humans to prokaryotes, with 35% sequence identity be-
tween most divergent species, suggesting a very high evolutionary conservation of the protein
(Kawabe et al., 2001). In silico analysis of WRNIP1’s sequence revealed two conserved domains:
an N-terminal UBZ (ubiquitin-binding zinc ﬁnger) and a central ATPase domain of the AAA+
type (ATPases associated with various cellular activities) (Kawabe et al., 2001). The UBZ domain
is characteristic for proteins of the post-replicative repair pathways, such as TLS polymerases or
RAD18 that use it to recognise modiﬁed PCNA. Structural studies of the UBZ motif showed that
it is identical to the one found in RAD18, but diﬀerent to Polη (Suzuki et al., 2016). WRNIP1’s
UBZ was found to be important for binding ubiquitin, with a preference for poly-chains, and for
monoubiquitylation of the protein itself in a process called coupled monoubiquitylation (Bish and
Myers, 2007). The second conserved domain of WRNIP1, the AAA+ ATPase, shares homology
with clamp loader proteins, such as RFC, or bacterial RuvB – a component of already mentioned
RuvAB complex involved in replication fork reversal in bacteria. The domain possesses motifs
characteristic for the family – Walker A, Walker B and arginine ﬁnger, all of which are necessary
for the ATP hydrolysis reaction (Wendler et al., 2012). WRNIP1, similarly to most AAA+ ATPases,
forms oligomers, presumably homo-octamers (Tsurimoto et al., 2005), which seems to be impor-
tant for nuclear foci formation (Crosetto et al., 2008).
5.2 Cellular behaviour of WRNIP1
When analysed by immunoﬂuorescence microscopy, WRNIP1 localises almost exclusively to the
nucleus, where it shows a mainly diﬀuse staining with several puncta. Upon genotoxic treatment,
WRNIP1 re-localises to damage sites, which depends on its UBZ domain and a C-terminal third
of the protein, suggested to be important for oligomerisation (Crosetto et al. (2008), Nomura et al.
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(2012), Kanu et al. (2016)). More importantly, WRNIP1 was found to associate with replication
forks in two independent unbiased proteomic screens (Alabert et al. (2014), Dungrawala et al.
(2015)); the latter also showed that WRNIP1’s abundance increases immediately after replication
fork stalling by hydroxyurea, peaking at the 15 minutes’ time-point, suggesting that the protein
performs its function at an early stage of the replication stress response. Apart from functional
domains important forWRNIP1’s localisation to damage-induced foci, recruitment of the protein
seems to depend on ATMIN (ATM-interacting protein) and the ubiquitylation of PCNA, since de-
pletion of the E3 Ub ligase RAD18 or expression of the PCNA K164R mutant abrogates WRNIP1
foci formation after long aphidicolin treatment (Kanu et al., 2016).
5.3 WRNIP1 interactswithproteins involved in replication and the repli-
cation stress response
In support of Ub-PCNA-dependent recruitment, the yeast homologoue of WRNIP1, Mgs1, was
found to interact with modiﬁed PCNA in a UBZ-dependent manner and this interaction was im-
portant for Mgs1’s cellular function (Saugar et al., 2012). Other putative interactors that further
put WRNIP1 at the replisome include the replicative polymerase Polδ (Tsurimoto et al., 2005), the
replication fork remodeler ZRANB3 (Ciccia et al., 2012), the E3 ubiquitin ligase Rad18 (Yoshimura
et al., 2009) and TLS polymerase Polη (Yoshimura et al., 2014).
5.4 Involvement of WRNIP1 in replication stress response pathways
Apart from localisation studies and suggested interactors, there is a signiﬁcant body of evidence
from research in yeast that implicates WRNIP1/Mgs1 in the DNA damage response. While Mgs1
knock-out alone is neither lethal to cells, nor causes growth retardation or sensitivity to geno-
toxins, it is synthetic lethal or sick with the loss of any of the error-free PRR pathway factors –
Rad6, Rad18 or Rad5. The phenotype can be suppressed by boosting homologous recombination,
either via over-expression of Rad52 or blocking the Srs2-dependent anti-recombination (Hishida
and Ohno, 2002). Interestingly, the same study found that deletion of Mgs1 restores the growth of
a yeast strain, which has a replication-stress-inducing mutation in Polδ and over-expresses Hol-
liday junction resolvase RuvC, indicating that Mgs1 may be involved in the formation of 4-way
junctions at challenged replication forks. These ﬁndings suggest that Mgs1 acts in a replication
stress response pathway that is based on replication-coupled recombination. On the other hand,
overexpression ofMgs1 leads to hyper-recombination and sensitivity toMMS and HU, indicating
that the activity of the protein has to be carefully controlled (Hishida et al., 2001).
INTRODUCTION Bartlomiej Porebski
5. WRNIP1 23
5.5 Biochemical activities of WRNIP1
There were several attempts to characterise WRNIP1/Mgs1 activities in vitro. It was shown that
the yeast protein has a weak ATPase activity that is stimulated by the presence of DNA; ssDNA
stimulated the protein better than dsDNA. The study also reports thatMgs1 is able to anneal com-
plementary DNA strands, however, surprisingly, the presence of ATP inhibits the process (Hishida
et al., 2001). It should be noted though that the ssDNAmolecule used in these experiments was ei-
ther M13 bacteriophage DNA or a single-stranded plasmid, both of which can contain secondary
structures that may have been recognised by Mgs1. Two other studies report binding of human
WRNIP1 to DNA substrates mimicking a primer-template or a 3-way junction (Yoshimura et al.
(2009), Kanamori et al. (2011)). Interestingly, while WRNIP1 does not seem to have a strong activ-
ity on its own, the protein was found to stimulate biochemical activities of two of its interactors
– Polδ and Fen1. In both cases, the stimulation was either not dependent or even negatively inﬂu-
enced byWRNIP1’s ATPase activity (Kim et al. (2005), Tsurimoto et al. (2005)). These biochemical
data may suggest that WRNIP1 acts as an auxiliary factor, assisting other proteins in their activ-
ities rather than doing the work itself, partially explaining why its function is so problematic to
pinpoint.
5.6 WRNIP1 promotes ATM signaling in response to replication stress
and protects stalled replication forks from nucleolytic processing
Two very recent studies shed some light on WRNIP1’s cellular function. In 2015, WRNIP1 was
shown to be a part of the ATM signaling pathway activated in the response to replication stress by
bridging signaling from poly-ubiquitylated PCNA to the ATM cascade (Figure 8B). Interestingly,
ATM signaling activation in response to ionizing radiation was not aﬀected, raising the question
about the type of structure or event that triggers the cascade speciﬁcally upon replication fork
stalling. The authors proposed that a reversed fork might be a good candidate, based on the ﬁnd-
ings showing FBH1-dependent ATM signaling in response to hydroxyurea (Kanu et al. (2016),
Fugger et al. (2015)).
The second study, published in 2016, reported the ﬁrst speciﬁc cellular function of WRNIP1.
It was found that WRNIP1 is yet another factor ensuring the stability of a stalled replication fork,
protecting nascent DNA from MRE11-dependent degradation (Figure 8A). Using a combination
of DNA ﬁbres and proximity ligation assay, the authors propose that WRNIP1 acts epistatically
with BRCA2 in loading RAD51 onto ssDNA and then ensures its stability by counteracting the
anti-recombinogenic activity of FBH1. It was also shown that the ATPase activity of WRNIP1 is
not needed for the protection of stalled forks, but is required for the eﬃcient restart of a subset of
forks (Leuzzi et al., 2016).
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Figure 8: Proposed models for the cellular function of WRNIP1. (A) The role of WRNIP1 in stalled fork
protection (Leuzzi et al., 2016). (B) The role ofWRNIP1 in ATM signaling following replication stress (Kanu
et al., 2016).
Despite presenting a compelling set of data implicating WRNIP1 in the protection of stalled
replication forks, the suggested mechanism has several shortcomings. First, while FBH1 has been
shown to disrupt RAD51-ssDNA complexes, it was also shown to have pro-recombinogenic ac-
tivities and, above all, directly regress replication forks in response to HU (Fugger et al., 2015).
This could oﬀer an alternative explanation to the rescue of the fork protection that the authors
see whenWRNIP1-deﬁcient cells are depleted of FBH1, namely that WRNIP1 protects the stalled
fork downstreamof its reversal. The study addresses this by showing that inHU-treatedWRNIP1-
deﬁcient cells, there is an accumulation of exposed parental, rather than newly synthesised, ssDNA
resulting from fork degradation, which the authors interpret as an indication that stalled replica-
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tion forks are not reversed prior to degradation. It is however possible, that prolonged stalling of a
reversed fork causes its degradation beyond the branch point, which is diﬃcult to detect without
looking at the replication intermediates directly. Lastly, while the authors propose an ATPase-
dependent role of WRNIP1 in replication fork restart, the ATPase-dead mutant used in the study
has never been shown to have compromised ATP hydrolysis activity (Tsurimoto et al., 2005).
6 Hypothesis - WRNIP1 contributes to replication fork re-
versal
Since WRNIP1 was discovered sixteen years ago many attempts to understand its function have
been undertaken, however the picture is still far from coherent. Even though the protein is not
essential for survival in unperturbed conditions, it becomes essential when the replication fork
deals with replication stress. WRNIP1 then helps to avoid detrimental fork over-processing and,
putatively, is involved in fork restart, possibly by somehow inﬂuencing Polδ.
As a focus of this PhDThesis project, we decided to investigate the cellular function ofWRNIP1
in the context of the DNA damage response, by performing an extensive characterisation of the
protein in vitro and challenging these ﬁndings in cells. The project was initiated in 2013 when the
function of WRNIP1 was still completely unknown. By analysing available data, especially from
yeast genetic studies, at the timewe came upwith a hypothesis proposing thatWRNIP1 is involved
in the remodeling of stalled replication forks, either mediating the transaction directly or assisting
other factors in doing so. We based the hypothesis on the aforementioned observation that loss
of Mgs1 rescues the growth defect of a yeast pol3-13 strain over-expressing RuvC. It is assumed
that, due to a mutation in the catalytic subunit of the DNA Polδ, the pol3-13 strain experiences an
elevated level of replication stress, which leads to a higher incidence of remodeling events at the
fork, including fork regression into a 4-way junction. Such structures can then be processed by
the bacterial RuvC nuclease, causing replication fork collapse and, consequently, inviability of the
strain. Since deletion of Mgs1 alleviates this growth defects, we reasoned that the protein has to
somehow contribute to the generation of RuvC-cleavable structures. Moreover, it was reported
that Mgs1 has DNA annealing activity and possesses an ATPase domain. Based on all these ob-
servations, we reasoned that the protein could be a perfect candidate to reverse stalled replication
forks.
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METHODS
7 Genetic engineering methods
Transformation of bacteria
Chemically competent Escherichia coli DH10b/DH10bac cells were prepared by growing suspen-
sion culture in LBmedium until OD600 = 0.5-0.6, followed by centrifugation to pellet the cells. The
pellet was suspended in an appropriate volume of ice-cold TSB buﬀer (10% PEG-3350, 5% DMSO,
10 mMMgCl2, 10 mMMgSO4 in LB; ﬁltered). The transformation was done by mixing 1-100 ng
DNA with the KCM buﬀer (100 mM KCl, 30 mM CaCl2, 50 mM MgCl2 in water; ﬁltered) and
competent bacteria, followed by 10 min. incubation on ice and subsequent 15 min. incubation at
RT. Afterwards, 400 µl S.O.C. medium was added, the cells were incubated at 37 °C with shaking
(45min for DH10b, 4 h for DH10bac), plated on an LB-agar plate and incubated overnight at 37 °C.
Propagation of plasmids
After transformation, several transformant clones were grown over-night in liquid LB medium
suppliedwith appropriate antibiotics. PlasmidDNAwas extracted using theQIAprep SpinMiniprep
Kit or QIAGEN Plasmid Plus Kit (Qiagen).
Polymerase chain reaction
Unless otherwise stated, the polymerase chain reaction (PCR) was assembled according to the Fig-
ure 9A and performed using a protocol outlined in Figure 9B. In general, the analytical PCR was
done using GoTaq® G2 DNA Polymerase (Promega) with extension time 60 s/kbp, while prepar-
ative and SDM (site-directed mutagenesis) PCR using the Phusion®Hot Start II DNA Polymerase
(New England Biolabs) with the extension time 20 s/kbp.
Figure 9: Conditions of PCR reactions. (A) PCR reaction mix. (B) PCR reaction program
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Figure 10: List of primers used in this study
cDNA cloning
WRNIP1S, ZRANB3 and HLTF cDNA were purchased from the Mammalian Gene Collection
(Dharmacon) as bacterial stabs (clone IDs: WRNIP1, no data; ZRANB3, 3077975; HLTF, 6015181).
Subsequently, the cDNA was ampliﬁed by PCR using appropriate pair of primers ﬂanked by attB
recombination sites. The PCR product was isolated by TBE-agarose gel electrophoresis and pu-
riﬁed using the QIAquick Gel Extraction Kit (Qiagen). Next, attB-cDNA was cloned into the
pDONR221™ GATEWAY® entry vector (Invitrogen) according to the manufacturer’s protocol
and transformed into competent bacteria. Cloning ofWRNIP1-L cDNAwas done by series of PCR
reactions onWRNIP1S-pDONR221 vector. Brieﬂy, in the ﬁrst step regions ﬂanking the insertion
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were ampliﬁed using primer pairs oBP21+22 and oBP23+24; PCR products were puriﬁed as de-
scribed above. Second PCR reaction was done using both amplicons mixed with oligonucleotides
oBP19+20. The full product was isolated and cloned into pDONR221 vector as described above.
Site-directed mutagenesis
Site-directed mutagenesis was performed according to the original idea of Stratagene
(QuikChange® Site-Directed Mutagenesis, Stratagene). Brieﬂy, PCR on a cDNA-pDONR221 vec-
tor was performed using long primers containing desired mutation in the middle; primers an-
nealed to the same fragment of cDNA, therefore the whole vector was ampliﬁed. High-ﬁdelity
polymerase was used to avoid any extra mutations. Afterwards, 10 U of DpnI (New England Bi-
olabs) restriction enzyme was added to degrade parental DNA and the mixture was incubated
for 1-2 h at 37 °C. The DNA was puriﬁed using the QIAquick PCR Puriﬁcation Kit (Qiagen) and
transfected and propagated in bacteria as described above. Isolated plasmid DNAwas checked for
desired and extra mutations by sequencing (Microsynth).
Generation of destination vectors
GATEWAY® destination vectors were generated according to manufacturer’s protocol (Invitro-
gen) and propagated in bacteria as described above.
RT-PCR
For WRNIP1 mRNA analysis, the total RNA was extracted from U2OS cells using the RNeasy
Mini Kit (Qiagen). Then, the cDNA synthesis was done using theHighCapacity RNA-to-cDNAKit
(Applied Biosystems) according to the manufacturer’s protocol, followed by a PCRwithWRNIP1-
speciﬁc primers oBP37+oBP38.
8 General mammalian cells methods
Cell culture
All human cell lines were grown in DMEM (Dulbecco’s Modiﬁed Eagle Medium, Gibco) supplied
with 10% fetal bovine serum (Gibco) at 37 °C and 5% CO2. Cells were split into a fresh medium
upon reaching sub-conﬂuency (2-3 times per week). For replicates of phenotypical analyses, cells
of similar passage number were always used (±2) to ensure reproducibility of conditions. Insect
Sf9 cells were grown in HyClone™ SFX-Insect™ cell culture media (GE Healthcare) at 25 °C with
shaking. Cells were split 2 times a week by diluting culture to 0.5-0.7 x106 cells/ml.
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Genotoxins and inhibitors
Aphidicolin, camptothecin and Mitomycin C were all purchased from Sigma-Aldrich, dissolved
in DMSO to a desired stock concentration (20 mM, 20 mM and 4 mM, respectively) and stored at
-20 °C; freshly thawed aliquot was always used. Hydroxyurea (Sigma-Aldrich) and 4NQO (Sigma-
Aldrich) were prepared freshly before every experiment as a 1 M stock in water and 5 mM stock
in ethanol, respectively. Zeocin™ was purchased from InvivoGen. Mirin was purchased from
Sigma-Aldrich, dissolved in DMSO to a ﬁnal concentration of 50 mM and stored at -80 °C.
Plasmid transfections
Transformation of bacmids to insect Sf9 cells was done using TransIT®-LT1 Transfection Reagent
(Mirus) according to manufacturer’s protocol. Human U2OS cells were transfected using
jetPRIME®(Polyplus-transfection®) according to manufacturer’s protocol (10 µg plasmid DNA
per 10 cm culture dish; 1:2 (w/v) DNA:jetPRIME ratio); medium was replaced after 6-8 hours.
HEK 293T cells were transfected using calcium phosphate in no-FCS medium. Brieﬂy, DNA (5
µg each plasmid) was mixed with CaCl2 (ﬁnal 250 mM) in sterile water. Next, equal volume of
2x HBS (280 mM NaCl, 50 mM HEPES, 1.5 mM Na2HPO4 in water) buﬀer was added while the
sample was vortexed at low speed. The mixture was incubated at RT for 20 minutes and added to
the cells drop-wise. After 6-8 hours, the medium was changed.
RNA-interference
Short interfering RNA duplexes were designed using Sfold (http://sfold.wadsworth.org/), unless
otherwise stated, and synthesised at Microsynth. U2OS cells were transfected with siRNAs us-
ing DharmaFECT1 Tranfection Reagent (Dharmacon). Tranfection mix equal to 1:10 of culture
medium volume was prepared in Opti-MEM™ (Gibco) by mixing siRNA (ﬁnal 40 nM) with the
transfection reagent (0.55 µl per 100 µl of the mix, irrespective of the number of siRNAs used);
the mixture was incubated at RT for 10 minutes and added to the cells. The growth medium was
replaced after 24 hours. Sequences of siRNAs used in the study are listed in the Figure 11.
9 Generation of cell lines
Flp-In T-REx
HeLa Flp-In™ T-REx™ (Thermo Fisher) cell lines over-expressing YFP-taggedWRNIP1 isoforms
were generated by transfecting an empty cell line with the respective FlpIn-compatible vector
and a vector encoding the Flp-recombinase. Two days after the transfection, cells were put under
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Figure 11: List of siRNAs in this study
the antibiotic selection with Hygromycin B (Invivogen) and Blasticidin (Invivogen), according to
the manufacturer’s recommendations. The medium was changed twice a week to ensure proper
selection.
WRNIP1 knock-out cell lines
WRNIP1 knockout cells were generated using CRISPR-Cas9 technology. First, short guide RNA
targeting the ﬁrst exon of WRNIP1 was designed using free online tools – MIT CRISPR De-
sign (Massachusetts Institute of Technology, USA) and CCTop (Centre for Organismal Studies,
Heidelberg). The sgRNA with the highest score in both prediction algorithms was chosen: 5’ -
CGTGTCAGGACGCATCGTGT (CGG) - 3’. Next, a pEsgRNA vector (DU46129, MRC Dundee)
bearing chosen sgRNA was generated by site-directed mutagenesis according to the approach
described in (Munoz et al., 2014). Then, HeLa Flp-In T-REx or U2OS cells were co-transfected
with the pEsgWRNIP1 and the Cas9 expression (DU45731, MRC Dundee) vectors and cultured
for 48 hours. Cells were then seeded at low density in a 96-well plate to generate monoclonal
cultures. Genomic DNA was extracted from the rest of the transfected cells using a standard
phenol-chloroform isolation method. CRISPR-Cas9-targeted region was ampliﬁed by PCR using
oBP07+31 primer pair, the amplicon was digested with EaeI restriction enzyme (New England
Biolabs) and reactions were analysed by agarose gel electrophoresis.
10 Baculoviruses
Bacmid generation
Bacmids were generated using the Bac-to-Bac® Baculovirus Expression System (Invitrogen) ap-
proach. Brieﬂy, pFastBac-based vector was transfected into DH10bac competent cells. Transfor-
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mants were grown for 48 h under selective pressure that includes antibiotics, IPTG and X-gal.
All-white transformants were analysed by PCR according to the manufacturer’s design. Positive
clones were grown in suspension and the bacmids were isolated using the QIAmp DNAMini Kit.
If necessary, bacmids were analysed by PCR using the same approach as for transformant colonies.
Bacmids were stored at 4 °C.
Baculovirus generation
To produce baculoviruses, bacmids were ﬁrst transfected into Sf9 cells. The cells were seeded in
a 6-well plate at a density 0.9 x106 cells/ml and left to adhere for 30 min prior to the transfec-
tion. The transfection mix was prepared by combining 1-2 µg bacmid DNA with the transfection
reagent at 1:3 (w:v) ratio in 250 µl of the SFX medium. The mix was incubation at RT for 20 min
and added to the growth medium. Cells were incubated at 25 °C for 96 hours. Afterwards, the
medium was recovered and ﬁltered through 0.22 µm ﬁlter. Next, 1.25 ml of the resulting P1 bac-
ulovirus stock was used to infect 5 ml of Sf9 cells seeded at 1 x106 in a cell culture ﬂask. After 4
days, the growth medium was recovered and ﬁltered. The titer of the P2 stock was checked by in-
fecting 2 x106 adhered Sf9 cells with increasing amount of the baculovirus (0-100 µl), followed by
48 h incubation to allow for protein expression. Next, the cells were collected by scraping, lysed as
described above, and levels of the protein of interest were analysed by Western blotting. Minimal
volume of the baculovirus that resulted in maximal protein expression was assumed as a volume
giving multiplicity of infection (MOI) equal to 1 per 2 x106 cells. To amplify the baculovirus, Sf9
cell were seeded at 1 x106 cells/ml in a desired volume, infected with P2 virus stock at MOI = 0.1,
incubated for 96 h and processed as described above. To ensure optimal stability, all baculovirus
stock were supplied with 2% FBS (Gibco) and stored at 4 °C avoiding exposure to light.
11 Proteins isolation and puriﬁcation
Lysis
Unless otherwise stated, human and insect cells were lysed by incubating PBS-washed cell pellets
with 5 PCV (packed-cell volume) of the Lysis Buﬀer (50 mMNa-phosphate pH 7.0, 150 mMNaCl,
10% glycerol, 0.1%NP-40, 1 mMTCEP, 0.5 mMEDTA), supplied with protease inhibitors cocktail
(Roche) and, optionally, 0.1% Benzonase® (Sigma-Aldrich) or PhosSTOP™ (Roche), for 30min. on
ice with intermittent vortexing. Next, the lysate was spun down at 17,200 x g for 30 min at 4 °C.
The supernatant was collected. If needed, concentration of the lysate was analysed using Bradford
assay.
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Preparative puriﬁcation of proteins from insect cells
All WRNIP1 variants, ZRANB3 and HLTF were puriﬁed from insect Sf9 cells. Liquid culture at a
density 2x106 cells/ml was infected with the baculovirus at MOI = 1. Cells were incubated with
shaking at 25 °C for 48 hours and then harvested and lysed as described above. Resulting lysatewas
spun down at 4 °C in the Sorval™WX+ ultracentrifuge (Thermo Scientiﬁc) equipped with the T-
865 rotor at 37500 rpm for 1 hour. The supernatantwas collected andﬁltered through 0.45µmand
0.22 µm ﬁlters. The resulting cell lysate was incubated with 0.01 volumes of equilibrated ANTI-
FLAG® M2 beads (Sigma-Aldrich) for 2 hours at 4 °C with rotation. Afterwards, the beads were
washed 3 times 10min. in 10ml of the Lysis Buﬀer at 4 °Cwith rotation. Then, beads were washed
additional 3 times with the Storage Buﬀer (Lysis Buﬀer minus EDTA for WRNIP1; Lysis Buﬀer
minus EDTA and NP-40 for ZRANB3 and HLTF). Afterwards, bound proteins were eluted with 5
beads volumes of the Storage Buﬀer supplemented with the 3xFLAG® Peptide (Sigma-Aldrich) at
200 ng/ul for 2 hours, at 4 °C, with rotation. Afterwards, WRNIP1 was aliquoted, snap-frozen and
stored at -80 °C. ZRANB3 and HLTF were concentrated on a Amicon® Ultra Centrifugal Filters
(Merck Millipore) and loaded on a Superdex™ 200 10/300 GL size-exclusion chromatography
column coupled to the AKTA Pure Fast Protein Liquid Chromatography system (GE Healthcare).
Fractions were analysed by SDS-PAGE and those containing the protein of interest eluting at a
volume corresponding to its monomer were aliquoted, snap-frozen and stored at -80 °C.
Calibration of the Superdex 200 column was done using Low- and High-Molecular Weight
Gel Filtration Calibration Kits (GE Healthcare).
Isolation from human cells
Isolation of WRNIP1 was done by over-expression of Flag-tagged proteins in HEK 293T cells,
followed by the Flag-immunoprecipitation (Flag-IP). The cDNA transfection and cell lysis were
done as described above. For the Flag-IP, cell lysates were incubated with ANTI-FLAG®M2 beads
(Sigma-Aldrich), followed by washing in Lysis and Storage buﬀers and elution in the same fashion
as described for the puriﬁcation from insect cells.
Endogenous WRNIP1 complexes were isolated from U2OS cells. Cell extracts were prepared
as described above and cleared with 15 µl of the Protein G Sepharose® Fast Flow beads (PGS)
for 30 min at 4 °C with rotation. This step was done to remove any contaminants binding non-
speciﬁcally to the beads. Afterwards, pre-cleared extracts were mixed with 1 µg of the anti-WHIP
(G-2) antibody and incubated for 2 h at 4 °C with rotation. Next, 15 µl of fresh PGS beads was
added and the mixture was incubated for an additional 4 h at 4 °C with rotation. Beads were then
washed 3 times with 1 ml of the Lysis Buﬀer and boiled in 5 volumes of the 1X Laemmli sample
buﬀer.
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Protein analysis by Western blotting
For the protein analysis by Western blotting, samples were boiled in Laemmli sample buﬀer and
separated by SDS-PAGE run at 180 V for 1 h or 100 V for 2 h. Proteins were then transferred
onto a nitrocellulose or a PVDF membrane (GE Healthcare) at 100 V for 1-2 hours. Afterwards,
membranes were blocked in the 5% milk-TBST (Tris-buﬀered saline supplemented with 0.01%
Tween®20) solution for 30 minutes and incubated with a primary antibody solution (1:1000)
overnight at 4 °C. Then, membranes were brieﬂy washed with TBST and incubated with an ap-
propriate secondary antibody (1:5000) for 2 h at RT. The membranes were then washed several
timeswith TBST and the signal was developed using the Clarity™Western ECLBlotting Substrate
(Bio-Rad) or the SuperSignal™West Femto Maximum Sensitivity Substrate (Thermo Scientiﬁc).
Primary antibodies used for protein detection: β-Actin-HRP (sc-47778, Santa Cruz Biotech-
nology), ATR pS428 (28535, Cell Signaling Technology), CHK1 pS345 (2348; Cell Signaling Tech-
nology), CHK2 pT68 (2661, Cell Signaling Technology), DNA-PKcs (ab1832, Abcam), Flag M2
(F1804, Sigma-Aldrich), HA-tag (A01244-100, GeneScript), H2A.X pS139 (9718, Cell Signaling
Technology), HLTF (GTX114776, GeneTex), KAP1 pS824 rabbit (A300-767A; Bethyl Laborato-
ries), MRE11 (NB100-142, Novus Biologicals), NEDD8 (ALX-210-194-R200, Enzo Life Sciences),
(PCNA (sc-56, SantaCruzBiotechnology), RAD51 (sc-8349; SantaCruzBiotechnology, Inc.), RecQL-
1 (sc-166388; Santa Cruz Biotechnology), RNF20 (ab32629, Abcam), β-Tubulin (sc-9104, Santa
Cruz Biotechnology), WHIP G-2 (sc-377402, Santa Cruz Biotechnology), WHIP N-17 (sc-55437,
Santa Cruz Biotechnology), ZRANB3 (23111-1-AP, proteintech).
12 Assays in cells
Immunoﬂuorescence microscopy of cells
Cells were seeded onto a 22 mm round coverslips and induced with 1 µg/ml doxycycline. After
48 h, cells were washed with PBS, ﬁxed with 3.7% formaldehyde in PBS for 10 min. and washed
3-times with PBS. Next, cells were permeabilised in 0.5% Triton/PBS for 15 min. at RT, followed
by washing with PBS and water. Finally, the slides were mounted with 5 µl Vectashield® with
DAPI. Cells were imaged using the Leica microscope, model DM6B, coupled to the DMC 2900
digital camera.
Clonogenic survival assay
Cells were seeded in a 24-well plate at a 300 cells/well density and allowed to attach for 6 hours.
Next, genotoxins were added directly to the growth medium. After 24 hours, the cells were re-
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leased into a drug-free medium and allowed to grow for 10-12 days. Next, cells were washed with
1x PBS, ﬁxed with ice-cold methanol for 10 minutes and incubated for 10 min at RT with the
staining solution (0.5% Crystal Violet in 25% methanol). The staining solution was removed, cell
were washed with tap water and air-dried before scanning on a ﬂatbed scanner (Epson Perfection
V850 Pro). The extent of growth was then quantiﬁed using the ColonyArea ImageJ plugin (Guz-
man et al., 2014). The graphs were prepared in the GraphPad Prism7, using mean values from 3
independent experiments, each consisting of 3 technical replicates (wells).
DNA ﬁbre spreading
Prior to the analysis of DNA ﬁbres, the cells were seeded in a 12-well plate at a density which will
ensure that the culture is 70-80% conﬂuent at the day of the labelling. Directly before labelling,
cells were washed 3 times with pre-warmed 1x PBS (phosphate-buﬀered saline). Next, the cells
were incubated with the medium containing 0.04 mM CldU (5-Chloro-2’deoxyuridine, Sigma-
Aldrich), followed by washing with pre-warmed PBS (3 times, brief). Subsequently, cells were in-
cubated with the medium containing 0.34 mM IdU (5’-Iodo-2’deoxyuridine, Sigma-Aldrich) and
a genotoxin, if indicated. Afterwards, cells were washed with PBS as previously and harvested by
trypsinisation. The cells were counted, diluted to 2.5 x105 cells/ml and mixed with the unlabelled
cells at 1:1 ratio. Then, 3 µl of cells suspension was spotted onto a glass slide, 7 µl of Fibre Lysis
buﬀer was added (200 mM Tris-Cl pH 7.4, 50 mM EDTA, 0.5% SDS in a sterilised water; ﬁltered)
and the drop was pipetted up and down 5 times, avoiding drop expansion. Slides were incubated
at RT for 9 minutes and tilted manually at an angle that allowing the drop to slide smoothly down
to the bottom of the slide. Next, the slides were air dried and ﬁxed at 4 °C overnight in the 3:1
mix of methanol and glacial acetic acid. The slides were then washed in 1x PBS (2 x 3 min) and
DNA was denatured in the 2.5 M HCl for 1 h at RT. The slides were washed in 1x PBS (2 x 3 min)
and subsequently blocked in a freshly prepared IF Blocking buﬀer (1x PBS containing 2% Bovine
serum albumin and 0.1% Tween®20; ﬁltered) for 40 min at RT. Next, 60 µl of the primary anti-
bodies mix (mouse α-BrdU/IdU (347580, Becton Dickinson) at 1:80, rat α-BrdU/CldU (ab6326,
Abcam) at 1:500, in the IF Blocking buﬀer) was added on top of the slide and the slide was covered
with a cover slip. The slides were incubated at RT for 2.5 h, Next, the cover slips carefully removed
and the slides were washed with PBST (1x PBS containing 0.2% Tween®20; 5 x 3 min), followed
by incubation with the secondary antibodies mix (Alexa488-conjugated α-mouse (A-11001, Invit-
rogen) at 1:300 and Cy3-conjugated α-rabbit (712-165-153, Jackson ImmunoResearch) at 1:300,
in the IF Blocking buﬀer) and washing in the same way as for the primary antibodies. Subse-
quently, the slides were air dried in dark and mounted with 20 µl of the ProLong™Gold Antifade
Mountant (Invitrogen). The slides were stored at 4 °C. DNA ﬁbres were visualised (60X objective,
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IX81, Olympus coupled to a CCD camera, Hammatsu) and scored using ImageJ; for each biolog-
ical replicate 100-200 molecules were scored, the IdU:CldU ratio was calculated for each ﬁbre
and the median value was extracted. Statistical analysis on median values from three independent
biological replicates was done in the GraphPad Prism7 software using one-way ANOVA.
13 Mass spectrometry analysis of WRNIP1 interactome
Sample preparation
Protein complexes that were subjected to the mass spectrometry analysis were prepared as de-
scribed above, with the exception for the samples that were cross-linked. The cross-linking was
done by incubating cellswith PBS containing 1mMDSP (3,3-Dithio-bis-(sulfosuccinimidyl)propionate,
EMDMillipore) for 30 min. at 37 °C. The reaction was quenched for 15min. at room temperature
by the addition of Tris-HCl to a ﬁnal concentration of 20 mM. Cells were then washed with PBS
and collected by scraping. Cell pellets were resuspended in 5 PCV of the Lysis Buﬀer from which
reducing agent – TCEP – was omitted. The Lysis Buﬀer was supplied with proteases inhibotors
and Benzonase nuclease, as described above. Mixtures were incubated for 30 min. on ice and son-
icated in a water bath sonicator Bioruptor (Diagenode) until the solutions were clear. Lysates were
spun down, supernatants collected and normalised using the Bradford assay. Afterwards, protein
complexes were isolated by the Flag-IP as described above, except in all steps the reducing agent
was omitted. After the elution, cross-links were reversed by the addition of DTT (ditiotreitol) to a
ﬁnal concentration of 50 mM and 1-hour incubation at 37 °C. The samples were analysed by mass
spectrometry at the Functional Genomics Center Zurich.
Sample analysis by mass spectrometry
Samples were precipitated with an equal volume of 20% trichloroacetic acid (TCA; Sigma-Aldrich)
and washed twice with cold acetone. The dry pellets were dissolved in 45 ml buﬀer (10 mM Tris
[pH 8.2], 2 mM CaCl2) and 5 ml trypsin (100 ng/ml in 10 mM HCl) for digestion, which was car-
ried out in a microwave instrument (Discover System; CEM) for 30min at 5W and 60 °C. Samples
were dried in a SpeedVac (Savant). For liquid chromatography (LC)-tandem mass spectrometry
(MS/MS) analysis, the samples were dissolved in 0.1% formic acid (Romil) and an aliquot ranging
from 5% to 25% was analyzed on a nanoAcquity UPLC System (Waters) connected to a Q Exactive
mass spectrometer (Thermo Scientiﬁc) equipped with a Digital PicoView source (New Objective).
Peptides were trapped on a Symmetry C18 trap column (5 mm, 180 mm 3 20 mm; Waters) and
separated on a BEH300 C18 column (1.7 mm, 75mm 3 150m; Waters) at a ﬂow rate of 250 nl/min
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using a gradient from 1% solvent B (0.1% formic acid in acetonitrile; Romil)/99% solvent A (0.1%
formic acid in water; Romil) to 40% solvent B/60% solvent A within 90 min. Mass spectrometry
settings for the data-dependent analysis were as follows: (1) precursor scan range, mass-to-charge
ratio (m/z) of 350–1,500; resolution, 70,000; maximum injection time, 100ms; and threshold, 3e6;
and (2) fragment ion scan range, 200–2,000 m/z; resolution, 35,000; maximum injection time, 120
ms; and threshold, 1e5.
Proteins were identiﬁed using the Mascot search engine (version 2.4.1; Matrix Science). Mas-
cot was set up to search the Swiss-Prot database assuming the digestion enzyme trypsin. Mascot
was searched with a fragment ion mass tolerance of 0.030 Da and a parent ion tolerance of 10.0
ppm. Oxidation of methionine was speciﬁed in Mascot as a variable modiﬁcation. Scaﬀold (Pro-
teome Software) was used to validate MS/MS-based peptide and protein identiﬁcations. Peptide
identiﬁcations were accepted if they achieved a false discovery rate (FDR) of less than 0.1% by the
scaﬀold local FDR algorithm. Protein identiﬁcations were accepted if they achieved an FDR of less
than 1.0% and contained at least two identiﬁed peptides.
14 Biochemical assays
DNA substrates
All the oligonucleotides used for DNA substrates preparationwere synthesised byMicrosynth and
are listed together with DNA structures in the Figure 11. Oligonucleotide X01 served as a basis
for all substrates used in this study and was therefore labelled on the 5’-end either by FAM (ﬂu-
orescein amidite) during the synthesis or by the kinase-mediated reaction with ATP γ-32P. The
radioactive labelling was done in 10 µl reactions containing 1 µMX01, 10 U T4 Poluynucleotide
Kinase (Thermo Scientiﬁc™), PNK buﬀer (Thermo Scientiﬁc™) and 25 µCi ATP γ-32P. The reac-
tion was incubated at 37 °C for 30 min, followed by puriﬁcation on two illustra MicroSpin G-25
columns (GE Healthcare).
Annealing of DNA substrates was done in a buﬀer containing 10 mMTris-HCl pH 8.0, 50 mM
NaCl and 10 mM MgCl2. Oligonucleotides were mixed, incubated for 5 min at 95 °C and then
allowed to cool down to room temperature. The ﬁnal concentration of resulting DNA substrates
was 100 nM for FAM-labelled substrates (10X stock) and 50 nM (50X stock) for the radioactive
substrates. The substrates were stored at -20 °C.
DNA binding
DNAbindingwas done in 10µl reactions containing 1µl of a DNA substrate (ﬁnal concentrations:
1 nM for radioactive and 10 nM for ﬂuorescent substrates) and 9 µl of protein-storage buﬀer mix.
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Figure 12: Oligonucleutides-based DNA substrates (A) List of oligonucleotides used for substrate an-
nealing. (B) List of DNA structures and their constituents.
Reactions were incubated on ice for 30min., followed by the addition of loading buﬀer (unfolding:
0.1% SDS, 10 mMEDTA, 2% Ficoll, Bromophenol Blue; native: 3.5% Ficoll, 10 mMTris-Cl pH 7.5)
and analysis by native gel electrophoresis using 0.5X TBE 5% polyacrylamide gels.
ATPase activity assay
ATPase activity assay was done in 5 µl reactions containing 5 mM MgCl2, 0.01 mM ATP, 0.033
µMATP γ-32P analysed protein and, optionally, 50 nM of a DNA substrate. In the control sample,
protein was replaced by the respective storage buﬀer. Reactions were incubated at 37 °C for 30
minutes and then stopped by the addition of EDTA to a ﬁnal concentration of 50 mM. Two 1-µl
samples were spotted on a PEI-Cellulose F thin-layer chromatoghraphy plates (Merck-Millipore)
and the plates were resolved in a mixture of 0.15 M LiCl and 0.15 M formic acid. Resolved plates
were air-dried and analysed by autoradiography.
Branch migration and fork reversal assays
Branchmigration assaywas done in 10µl reactions containing 1 nMDNAsubstrate (radioactively-
labelled), 100 µg/ml BSA (New England Biolabs), 1 mM ATP, 0.5 mMMgCl2 and the protein(s) of
interest. Reactions were carried out at 37 °C. Reactions were deproteinized for 20 min at 37 °C
with 2mg/ml Proteinase K and 0.4% SDS and resolved by native PAGE through 8%polyacrylamide
gels in TBE.
METHODS Bartlomiej Porebski
15. BIOINFORMATICS 39
In vitro fork reversal was done in a similar fashion, except the deproteinised reactions were
analysed by electrophoresis through 1% agarose in TBE buﬀer containing 0.5 mg/ml ethidium
bromide.
15 Bioinformatics
Multiple-sequence alignment
Primary sequence alignment was done using Clustal Omega algorithm with default settings, ac-
cessed through the Uniprot website (www.uniprot.org). Accession numbers of aligned proteins
were: Q96S55-1 (H. sapiens), K7BSN9 (P. troglodytes), Q91XU0 (M. musculus), P40151 (S. cere-
visiae), P0AAZ4 (E. coli).
Structure prediction and analysis
Prediction of three-dimensional structures of both isoforms (Q96S55-1 and Q96S55-2) was done
using Phyre2 (Protein Homology/analogy Recognition Engine V 2.0) algorithm and the models
were analysed using UCSF Chimera and PyMOL.
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RESULTS
16 Analysis of WRNIP1 isoforms
Due to alternative splicing, WRNIP1 transcripts are processed into two distinct mRNA isoforms.
Since the available literature regarding WRNIP1 does not mention the existence of two isoforms
nor provides any information as to which one was analysed, we decided to include both of them
in our analyses to identify diﬀerences and their potential signiﬁcance for protein function.
16.1 In silico analysis of WRNIP1 isoforms
First, a brief in silico analysis was performed. Primary sequence alignment of human WRNIP1’s
long isoform to the protein’s homologues from other species showed that themissing stretch of 25
amino acids is highly conserved and lies within the ATPase domain of the protein (Figure 13A). To
check whether this stretch changes the architecture of the catalytic pocket, the three-dimensional
structure models were analysed. The models were generated by prediction algorithm, based on
the solved structure of the bacterial homologoue ofWRNIP1, MgsA (Page et al., 2011). MgsA lacks
the N-terminal third, therefore the predicted models are N-terminally truncated. As shown in the
Figure 13B, both isoforms, referred to from now on as WRNIP1L (long, 72 kDa) and WRNIP1S
(short, 69 kDa), show a similar overall fold, except the C-terminal part, putatively responsible
for oligomerisation (Crosetto et al., 2008). Although the additional stretch of 25 amino acids lies
within the ATPase domain in close proximity to the motifs responsible for ATP hydrolysis, it does
not signiﬁcantly distort the catalytic pocket (Figure 13C).
16.2 Analysis of WRNIP1 isoforms in cells
Available transciptomics data suggest that, at least at the mRNA level, the long isoform is the pre-
dominant one across various healthy and cancer tissue types. Before commencing our analyses in
cells, we wanted to check which isoform is present in our model system – U2OS cells. In order to
do so, bulk mRNA from U2OS cells was ampliﬁed into cDNA by RT-PCR, followed by PCR with
WRNIP1-speciﬁc primers. Products corresponding to both isoforms were detected, however in
dramatically diﬀerent amounts (Figure 14A). Since only an end-point RT-PCR was performed, we
could not infer precise quantitative information, however the result clearly shows that the long
isoform is predominant in U2OS cells.
When analysed by Western blotting, endogenous WRNIP1 runs as a single band at around 90
kDa level. To check which isoform the band corresponds to, the two WRNIP1 isoforms were ec-
topically expressed in U2OS cells depleted of endogenous protein by siRNA targeting the 3’UTR
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Figure 13: In silico analysis of WRNIP1 isoforms. (A) Alignment of WRNIP1L primary sequence from
multiple species. The 25-aa insertion is shown in grey. Asterisk indicates complete residue conservation,
colon indicates conservation of amino acid chemical character. AAA+ ATPase motifs are shown in red
and violet. (B) Superimposition of predicted structures of WRNIP1L (green) and WRNIP1S (light blue).
Relevant domains are indicated with dashed elipses. (C) Comparison of the catalytic pockets of the two
WRNIP1 isoforms. Residues relevant for ATPase activity are indicated, color coding as in (A) and (B).
(Figure 14B). Both isoforms were strongly over-expressed compared to the endogenousWRNIP1,
and WRNIP1L was present at higher levels than WRNIP1S, which was observed reproducibly in
all experiments that involved expression of the two proteins. Their 3 kDa size diﬀerence allowed
to separate the two isoforms and compare their migration patterns to the endogenous protein,
showing that the endogenous WRNIP1 band corresponds to the long isoform. In two other com-
monly used cell lines – RPE-1 and HEK 293T – endogenousWRNIP1 displays the samemigration
pattern (Figure 14C).
Endogenous WRNIP1 localises to the nucleus, where it shows diﬀuse pan-nuclear staining
(TheHumanProteinAtlas). Some reports also suggest formation of small focal structures in unper-
turbed conditions (Crosetto et al., 2008). To verify localisation of WRNIP1 isoforms, HeLa FlpIn
T-REx cell lines expressing YFP-tagged proteins were generated and analysed by ﬂuorescence
microscopy (Figure 14D). Both isoforms localised to the nucleus, however, while Y FPWRNIP1S
showed only pan-nuclear staining, Y FPWRNIP1L additionally formed big bright foci.
To summarise, WRNIP1L seems to be the predominant, if not the only isoform present in the
cell. Also, an in silico analysis indicates that WRNIP1S and WRNIP1L have a similar overall fold
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and the additional 25-aa fragment does not seem to alter the ATPase domain in a signiﬁcant way.
The strikingly diﬀerent localisation of the two isoforms suggests that there may be a functional
diﬀerence.
Figure 14: Analysis of WRNIP1 isoforms in cells. (A) Experimental design and result of the end-point
RT-PCR analysis of WRNIP1 transcripts from U2OS cells. (B) and (C) Comparison of ectopically expressed
WRNIP1 isoforms to the endogenous protein. (D) Representative ﬂuorescence microscopy images of cell
lines over-expressing YFP-tagged WRNIP1 isoforms.
17 Puriﬁcation of WRNIP1
WRNIP1 was shown to oligomerise, both in cells (Crosetto et al., 2008) and in vitro (Tsurimoto
et al. (2005), ichi Kawabe et al. (2006)), reportedly assembling into homo-octamers, as assessed by
size-exclusion chromatography and glycerol-gradient ultracentrifugation (Tsurimoto et al., 2005).
17.1 Puriﬁcation of WRNIP1 variants
For the purpose of this study, we decided to purify a series of WRNIP1S/L variants, including
wild-type, UBZ-mutant and two ATPase-domain mutants, having a K274A mutation that aﬀects
the binding of an ATPmolecule or an E329Qmutation that allows for binding of ATP, but impairs
its hydrolysis (Figure 15A). The tag of choice was a Flag-tag, due to its small size, robustness and
already proven eﬃcacy in WRNIP1 puriﬁcation (Tsurimoto et al., 2005).
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WRNIP1 variants were expressed in insect Sf9 cells and puriﬁed according to the procedure
depicted in Figure 15B. This simple and fast procedure yielded recombinant protein of high con-
centration and purity (Figure 15C). Puriﬁed WRNIP1 migrated as two bands, with the minor,
higher one representing the protein modiﬁed with a single ubiquitin moiety. The band represent-
ing ubiquitylatedWRNIP1was absent in the UBZ-mutant, which is in line with reports suggesting
that WRNIP1 undergoes coupled mono-ubiquitylation, i.e. ubiquitylation that requires an intact
UBZ domain. Of note, puriﬁcation of WRNIP1S variants was less robust, yielding protein prepa-
rations of lower concentration and purity.
17.2 WRNIP1 puriﬁes as a high-molecular weight complex
To assess whether puriﬁed WRNIP1 forms oligomers, as reported in the literature, analytical gel
ﬁltration was done (Figure 15D). Both WRNIP1 isoforms eluted as high-molecular weight (MW )
complexes, with the elution volume similar to the 669-kDa thyroglobulin size marker. The size
of monomeric WRNIP1 is 72 and 69 kDa for the long and short isoform, respectively, therefore
the apparent size of the complex exceeds the theoretical weight for an octamer. However, size
exclusion-based resolution of molecules depends on the radius of an analysed molecule, rather
than its factual size, thus providing only an estimate of themolecularweight. Interestingly,WRNIP1S
gave an additional small peak at 12.65 ml, which, according to the standard curve, corresponds
to a 70-kDa molecule. It could either represent monomeric WRNIP1S or the aforementioned
contaminant of similar size (Figure 15C). To further investigate WRNIP1’s oligomeric state, non-
denaturating Western blotting was performed (Figure 15E). The bulk of the protein migrated as
high-MW complexes, in line with the gel ﬁltration results. Longer exposure times revealed also
lower-MW populations of WRNIP1, but these were present only in WRNIP1S and, to a lesser
extent, in K274A-WRNIP1L preparations. Similar to the gel ﬁltration chromatography, the size
estimation in native-PAGE is imprecise, since the electrophoretic migration depends on the pro-
tein’s charge in its native state and cannot be directly related to size markers. Nevertheless, my
data clearly show that WRNIP1 predominantly assembles high-order oligomers, which is in line
with published data.
18 Biochemical activities of WRNIP1
Several groups have attempted to studyWRNIP1’s activities in vitro. It was found that the protein
binds DNA, although there is no consensus about its substrate preference (Yoshimura et al. (2009),
Kanamori et al. (2011)). WRNIP1was also found to have a ssDNA annealing activity (Hishida et al.,
2001) and stimulate DNA Polymeraseδ (Tsurimoto et al., 2005), however both of these functions
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Figure 15: Puriﬁcation of WRNIP1. (A) ) Schematic of WRNIP1 isoforms with indicated mutations
that were introduced. (B) Strategy of puriﬁcation. (C) Commassie-stained SDS gel showing all puriﬁed
proteins. Equal volumes were analysed. Dashed lines indicate excised irrelevant lanes. (D) Chromatogram
of Superdex200 size-exclusion analysis of puriﬁed wild-type WRNIP1 isoforms. (E) Analysis of puriﬁed
WRNIP1 proteins by native PAGE.
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were inhibited, rather than driven, by the presence of ATP, leaving the question about WRNIP1’s
enzymatic activity still open.
18.1 WRNIP1 binds DNA with a preference for 4-way junctions
Since we suspected a role for WRNIP1 at stalled replication forks, we tested whether it is able to
bind to structures that can arise during replication fork remodeling, such as three- or four-way
junctions. In EMSA (electrophoretic mobility shift assay) with a series of oligonucleotide-based
DNA substrates, WRNIP1 showed a clear preference for structures having a branch-point, such as
splayed arms or 3- or 4-way junctions (Figure 16A). Closer analysis done by titration of WRNIP1
into a ﬁxed amount of branched substrates showed that WRNIP1 has the highest preference for
a 4-way junction substrate, a structure that resembles a reversed replication fork. Due to the fact
that WRNIP1 forms high-MW oligomers it was diﬃcult to analyse its protein-DNA complexes
by electorphoresis. The observed smearing could be caused by low gel percentage or by dynamic
complex assembly-disassembly cycles. Also, the shifted DNA band was often retained in the well,
whichmay be attributed either to the size of the protein-DNAcomplexes or the presence of protein
aggregates. To address this issue, the procedure was optimised. The improved protocol gave inter-
esting results: apart from the bands retained in the wells of the gel, observed for most substrates
and both isoforms, there was a population of fast-migrating WRNIP1-DNA complexes seen only
for the 4-way junction substrate and WRNIP1S, but not WRNIP1L (Figure 16B). Further analysis
showed that allWRNIP1S variants andK274A-WRNIP1L follow the same behaviour (Figure 16C).
Above data shows that WRNIP1 has the ability to bind to DNA structures that can arise dur-
ing stalled fork remodeling. Interestingly, only WRNIP1 preparations that putatively contain
monomeric WRNIP1 (Figure 15E) showed speciﬁc binding to a 4-way junction substrate that
mimics a reversed replication fork.
18.2 WRNIP1 has no branch migration and a weak ATPase activity
Since WRNIP1’s ATPase domain is homologous to the one found in bacterial replication fork re-
modeling enzyme RuvB, we wondered whether WRNIP1 could have similar activity. To establish
whether WRNIP1 is able to directly remodel replication fork intermediates, DNA branch migra-
tion activity was assayed, using 3- or 4-way junction substrates in which the branching point can
be moved, mimicking fork reversal and fork restoration reactions, respectively. Such an activity
is a feature of fork remodeling helicases and translocases that were introduced earlier. Neither of
WRNIP1 isoforms could catalyse branch migration of three- or four-way junction, in contrast to
the DNA translocase ZRANB3 (Figure 17A).
Due to the failure to detect any branch migration activity, the ATPase activity of WRNIP1 was
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Figure 16: Analysis of WRNIP1’s DNA binding abilities by EMSA. (A) Binding of WRNIP1S (upper
panel) andWRNIP1L (lower panels) to radioactively labeled DNA substrates under mildly unfolding condi-
tions (0.1% SDS). (B) Binding of wild-typeWRNIP1S andWRNIP1L to FAM-labeled DNA substrates under
native conditions. (C) Binding of all puriﬁed WRNIP1 variants to 3- and 4-way junction substrates under
native conditions.
tested, using an assay that measures the release of radioactive gamma-phosphate group from an
ATP molecule. Surprisingly, neither WRNIP1 isoform showed any ATPase activity, in striking
contrast to another potent DNA translocase, HLTF (Figure 17B).
19 Physical and functional interactions of WRNIP1
WRNIP1 was suggested to interact with several proteins involved in DNA replication or DNA-
damage response pathways, such as Polδ, WRN, ZRANB3 or ATMIN (Kanu et al., 2016). To gain
further insight intoWRNIP1’s function, we decided to use an unbiased approach in order to char-
acterise the interaction network of WRNIP1 in cells.
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Figure 17: Analysis of WRNIP1’s biochemical activities. (A) Branch migration activity of WRNIP1S
(left panel) and WRNIP1L (right panel) on radioactively labeled moveable 3- and 4-way junctions.
(B) ATPase activity of all puriﬁed WRNIP1 variants. Upper panel - representative scan of a TLC plate;
lower panel - quantiﬁcation of the released phosphate group, represented as a fold change relatively to the
control sample
19.1 WRNIP1 forms transient interactions at replication forks
Prior to mass spectrometry, Flag- or YFP-tagged WRNIP1 was overexpressed in cells, followed
by aﬃnity puriﬁcation, washing-oﬀ of contaminants and elution of residual bound proteins. Sur-
prisingly, apart from the usual contaminants, nomeaningful hits were identiﬁed, including already
established interactors. Although WRNIP1’s presence at the replication fork had been shown in
several proteomic studies, not a single replisome-associated protein was found in the analysed
samples. This result was reproducible irrespective of the cell line (HEK 293T, HEK 293 FlpIn T-
REx, HeLa, HeLa FlpIn T-REx), the tag (Flag, YFP) and the subcellular fraction (cytoplasm, nuclear)
Even isolation of endogenous WRNIP1 did not give any meaningful data. Finally, as a last resort,
in vivo crosslinking was done prior to protein isolation. As seen in the Venn diagram (Figure
18A), this approach turned out to be successful. 937 proteins were identiﬁed in the Flag-pull-
down sample when protein complexes were cross-linked beforehand, compared to only 262 in
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the non-cross-linked sample. A group of 220 proteins was common for both datasets, howev-
erm the majority of it (187) overlapped with the control set. As expected, a signiﬁcant number
of proteins identiﬁed in the cross-linked Flag-WRNIP1L pull-down was also found in the control
sample (404), however, more than half of the hits were unique. Importantly, among these were
all of the core components of the replisome, suggesting that WRNIP1L localises to the replica-
tion fork, which is in line with the literature. Moreover, a number of DNA damage and replica-
tion stress response proteins were found, including several that are involved in stalled replication
fork-remodeling (HLTF, PARP1, RECQ1, MRE11) or the ubiquitin-system. A full list of mean-
ingful hits reproducibly found in several replicates is given in Figure 18B. Although cross-linking
greatly improved the result, it should be kept in mind that such an approach may identify many
indirect interaction partners or false-positives that were isolated by simply being in close prox-
imity to WRNIP1.
To validate some of the candidate interacting proteins, endogenous WRNIP1 was isolated
from untreated and hydroxyurea-treated U2OS cells. The choice of the dosage and duration of
treatmentwas based onproteomics studies, whereWRNIP1 showed the highest abundance shortly
after replication fork stalling (Dungrawala et al., 2015). Despite promisingmass spectrometry data,
none of the tested proteins was immuno-precipitated together with WRNIP1, irrespective of the
conditions (Figure 18C). Surprisingly, mass spectrometry data could not be conﬁrmed byWestern
blotting even when the same samples were analysed (data not shown). It is thus possible that the
interactions are too weak or that only a small subpopulation of WRNIP1 exists in multi-protein
complexes, eluding detection by most commonly used methods. Of note, none of the reported
WRNIP1 interactors, such as WRN (Kawabe et al., 2001), RAD51, BRCA2 (Leuzzi et al., 2016),
ATMIN (Kanu et al., 2016) or ZRANB3 (Ciccia et al., 2012) was found.
19.2 WRNIP1 interacts with ZRANB3 in vitro
GivenWRNIP1’s potential role at stalled replication forks, wewere in particular interested to have
a closer look at a possible interaction between WRNIP1 and ZRANB3. Previously, the two pro-
teins were found to co-localise at UV-induced damage sites, however only if de-ubiquitylation of
PCNA and signaling through PIK kinases were blocked (Ciccia et al., 2012). Moreover, WRNIP1
co-precipitated with tagged-ZRANB3, yet only upon formaldehyde-induced cross-linking in ad-
dition to the aforementioned treatments (Ciccia et al., 2012). To further investigate the inter-
action, both proteins were co-overexpressed in insect cells, followed by immuno-precipitation.
Since WRNIP1 is mono-ubiquitylated in a UBZ-dependent manner and ZRANB3’s function in
response to replication stress depends, among others, on its ubiquitin-binding NZF domain (Ci-
ccia et al. (2012), Vujanovic et al. (2017)), the UBZ-mutant D37A WRNIP1 was included in the
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Figure 18: WRNIP1 interactome. (A) Venn diagram of datasets containing proteins identiﬁed by mass
spectrometry in the three indicated conditions. The numbers indicate number of individual proteins. Sizes
of circles are proportional to the amount of identiﬁed proteins. (B) List of signiﬁcant hits reproducibly
found in mass spectrometry analyses. (C) Western blotting analysis of endogenous WRNIP1 pull-down
from U2OS cells. (D) Western blotting analysis of co-puriﬁcation of WRNIP1 and ZRANB3 from insect
cells. Asterisk indicates WRNIP1 degradation product.
analysis. As seen in Figure 18D, both variants of WRNIP1 co-puriﬁed with Flag-ZRANB3 and
the interaction was independent of WRNIP1 ubiquitylation. Interestingly, WRNIP1S was repro-
ducibly pulled-down more eﬃciently than WRNIP1L, despite being expressed at lower levels.
19.3 WRNIP1 inﬂuences ZRANB3’s branch migration activity
The fact that WRNIP1 interacts with a known replication fork remodeler, but has no intrinsic
branch migration activity may indicate that the protein might act as an auxiliary factor that indi-
rectly participates in fork remodeling. To validate this hypothesis, a branch migration assay was
performedwith oligonucleotide-based substrates, usingZRANB3 in combinationwithWRNIP1L.
Proteins were added at the same time or one of the proteins was pre-incubated with the substrate,
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before addition of the other and starting the reaction by ATP (Figure 19A). In all of the tested sce-
narios, WRNIP1L did not aﬀect product formation by ZRANB3. The same result was obtained for
WRNIP1S (data not shown). To exclude the possibility that an eﬀect ofWRNIP1 cannot be reliably
detected on a short oligonucleotide-based substrate that was used in the assays, a plasmid-based
replication fork was then used (Figure 19B, upper panel). Such a substrate had been previously
used to assess in vitro fork reversal activity of FANCM (Gari et al., 2008a), HLTF (Blastyak et al.,
2010), ZRANB3, SMARCAL1 (Ciccia et al., 2012) and FBH1 (Fugger et al., 2015). As expected,
WRNIP1L had no fork reversal activity (Figure 19B, lanes 2-4), in contrast to ZRANB3 (lane 5).
Interestingly, titration of WRNIP1L into the reaction with ZRANB3 decreased accumulation of
the end product, suggesting that WRNIP1L can inhibit long-range fork reversal by ZRANB3.
20 Function of WRNIP1 in cells
The cellular function of WRNIP1 has been diﬃcult to establish since the moment the protein
was identiﬁed. Until 2016, when WRNIP1 was shown to be involved in the protection of stalled
replication forks, all accumulated observations did not allow to unequivocally characterise the
protein’s function. Since there was no data on any phenotype caused byWRNIP1 loss, we decided
to investigate it with a series of commonly used assays.
20.1 WRNIP1 loss does not alter the response to genotoxic treatment
Loss of a factor involved in the DNA damage- or replication stress response frequently causes
altered sensitivity to genotoxic agents. However, loss of WRNIP1 did not cause any signiﬁcant
change of cells survival upon treatment with a panel of genotoxins, which included drugs induc-
ing physical damage, such as CPT, MMC, 4NQO or Zeocin, and compounds known to induce
replication stress without modifying the DNA template, such as aphidicolin and HU (Figure 20A).
Two main kinases govern the cellular response to replication stress or DNA damage: ATR
and ATM. To assess whether loss of WRNIP1 changes these signaling events, the phosphorylation
status of ATM and ATR substrates was checked by Western blotting in response to (Figure 20B)
or upon recovery from (Figure 20C) HU-induced replication stress. In both cases the kinetics of
CHK1, CHK2 and KAP1 phosphorylation did not change signiﬁcantly whenWRNIP1 was absent.
In the case of phospho-H2AX, loss of WRNIP1 seemed to enhance the modiﬁcation upon longer
HU-treatment and slow-down the dissipation of phosphorylation in the recovery phase. Inter-
estingly, upon longer exposure times, it became evident that an up-shifted population of γH2AX,
putatively mono-ubiquitylated, follows similar kinetics, i.e. without WRNIP1 the basal level was
lower but got relatively more enhanced upon stress, and it persisted after the genotoxin was re-
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Figure 19: Functional interaction between WRNIP1 and ZRANB3. (A) Branch migration assay
analysing the inﬂuence of WRNIP1 on ZRANB3 activity. (B) Fork reversal assay on a plasmid-based sub-
strate. Upper panel - schematic of the assay; lower panel - inﬂuence ofWRNIP1L on ZRANB3 fork reversal
activity.
moved. Also, while phosphorylation of ATR did not seem aﬀected, an extra band detected with the
pATR S428 antibody around 100 kDa showed a diﬀerent pattern in WRNIP1-depleted cells com-
pared to the control. There are reports in literature suggesting that antibodies generated against
phosphorylated peptides can recognise other substrates having similar motifs, e.g. pMCM3 can
be detected by a pATM antibody (Mcmahon et al., 2012). The identity of the phosphorylated pro-
tein detected with the pATR antibody is unknown, however the data suggest that WRNIP1 can
inﬂuence its basal and stress-induced phosphorylation events.
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Figure 20: Phenotypical analysis of WRNIP1-deﬁcient U2OS cells. (A) Clonogenic assay. Quantiﬁ-
cation represents 3 independent biological replicates, each consisting of 3 technical replicates. (B) Western
blotting analysis of ATR and ATM signalling activation along hydroxyurea-treatment timecourse. (C)West-
ern blotting analysis of ATR and ATM signalling activation during recovery from hydroxyurea-induced
replication stress. (D) Analysis of replication dynamics by DNA ﬁbre spreading. One hundred to two hun-
dred molecules were scored for each condition. Horizontal line indicates median value, also given in red
above the graph. Statistical analysis: Mann-Whitney test; ns - non-signiﬁcant.
20.2 WRNIP1 does not inﬂuence replication dynamics upon replication
stress
It has been established that global replication fork progression slow-down is an immediate re-
sponse to a wide variety of genotoxic insults (Zellweger et al., 2015). It was further elucidated
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that a challenged replication fork undergoes reversal, which causes the observed decrease in fork
speed, when assayed byDNAﬁbre spreading (Zellweger et al. (2015), Vujanovic et al. (2017)). Based
on these ﬁndings, replication fork progression upon HU-induced stress was checked in cells de-
pleted of WRNIP1. Cells were sequentially pulse-labeled with halogenated thymidine analogues,
additionally supplementing the second label with hydroxyurea at a concentration known to slow-
down, but not stall replication fork progression (Figure 20D). WRNIP1 absence did not alter DNA
synthesis uponHU treatment, further suggesting that the protein is not required for stress-induced
replication fork reversal.
20.3 WRNIP1 protects stalled replication forks fromMRE11-dependent
degradation downstream of replication fork reversal
Recently, WRNIP1 was found to protect stalled replication forks fromMRE11-dependent degra-
dation (Leuzzi et al., 2016). The authors postulated that the protein acts together with BRCA2 to
stabilise RAD51 on ssDNA generated at an uncoupled replication fork. Since in the absence of
WRNIP1, MRE11-dependent degradation caused only parental ssDNA accumulation, the authors
argued that nascent DNA is degraded without prior replication fork reversal. In support of their
claim, depletion of RAD51, which should prevent fork reversal, did not rescue fork stability in a
WRNIP1-depleted background.
Figure 21: Nascent DNA degradation in WRNIP1-deﬁcient cells. DNA ﬁbre spreading analysis of
stalled fork degradation. Upper-left panel - experimental design. Lower-left panel - Western blotting anal-
ysis of knock-down eﬃciency. Right panel - DNA ﬁbre spreading results. Each dot represents an individual
biological replicate; at least one hundred molecules were scored in each replicate. Horizontal lines indicate
mean value, also given in red above the plot. Statistical analysis: one-way ANOVA; ns, not signiﬁcant; ****,
P<0.0001.
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Nevertheless, we decided to revisit these results and, knowing how complex the role of RAD51
at stalled replication forks is, to include other genetic conditions that would block replication fork
reversal. In order to do so, cells were pulse-labelled with thymidine analogues, followed by HU-
induced replication fork stalling (Figure 21A). After DNA ﬁbre spreading and imaging, the ratio
of IdU and CldU track lengths was calculated for each molecule. Next, the "extent of degradation"
was calculated for each sample relatively to the control sample. This was done to avoid variations
between biological replicates. After acquiring data from at least 3 independent biological repli-
cates, proper statistical tests were performed. The reason for such an experimental design was
to conﬁrm reproducibility of the results and enable a meaningful statistical analysis. As shown in
Figure 21B, depletion ofWRNIP1 caused nascent DNA degradation upon replication fork stalling.
However, in contrast to the literature, treatmentwithmirin, an inhibitor ofMRE11, did not rescue
replication fork protection. On the other hand, depletingMRE11 by two diﬀerent siRNA duplexes
did revert the degradation phenotype. A similar rescue result was obtained when replication fork
reversal was prevented by complete depletion of RAD51 or either of the fork reversing enzymes
ZRANB3 and HLTF.
To summarise, in line with the literature, WRNIP1 depletion causesMRE11-dependent degra-
dation of nascent DNA at a stalled replication fork. In contrast to the published model however,
my data clearly indicates that WRNIP1 exerts its protective function downstream of replication
fork reversal.
20.4 WRNIP1 knockout cells do not show nascent DNA degradation
To complement the studies in cells, WRNIP1 knock-out cell lines were generated using CRISPR-
Cas9 technology. The short guide RNA was designed to target the ﬁrst exon of WRNIP1, as seen
on the schematic (Figure 22A). The initial validation of the knockout was done by restriction-
digest of the targeted locus ampliﬁed from genomic DNA. The NHEJ-mediated processing of the
Cas9-generated double-strand break would lead to the loss of a restriction site, enabling an easy
estimation of knockout eﬃciency (Figure 22A). Using this approach, WRNIP1 knock-out HeLa
FlpIn T-REx andU2OS cell lines were generated in whichWRNIP1was completely absent (Figure
22B).
To determine whether the cell lines recapitulate the results obtained with transient knock-
down of the protein, stalled fork degradation was assessed, using standard DNA ﬁbre spreading
assay (Figure 22C). Surprisingly, both WRNIP1 knock-out cell lines were completely devoid of
stalled fork degradation and therefore were not used for any further analyses.
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Figure 22: Generation and analysis of WRNIP1 knockout cell lines. (A) Schematic of WRNIP1-
targeting short guide RNA design and experimental approach for knockout eﬃciency assessment. (B)West-
ern blotting analysis of WRNIP1 knock-out HeLa FlpIn T-REx (left) and U2OS (right) cell lines. (C) Stalled
replication fork degradation analysis in WRNIP1 knockout cells. Experimental design was the same as in
Figure 21A, except here, two biological replicates were analysed. Horizontal red lines indicate mean value.
20.5 WRNIP1 is modiﬁed in cells by ubiquitin and ubiquitin-like modi-
ﬁers
WRNIP1 was found to be modiﬁed by SUMO and ubiquitin, with the latter modiﬁcation depend-
ing entirely on an intact UBZ domain (Bish and Myers, 2007). Using mass spectrometry, the au-
thorswere able to suggest several lysines that could be ubiquitylated, however no follow-up studies
were done. Although the UBZ domain was implicated in targeting WRNIP1 to sites of replication
stress, it remains unclear whether it is WRNIP1’s ability to bind ubiquitin chains via the UBZ do-
main or UBZ-dependent ubiquitylation of the protein itself that drives the function. We decided
to investigate this further in an attempt to identify the modiﬁed residues in WRNIP1 and to elu-
cidate the role of PTMs in WRNIP1’s function.
Apart from the abovementioned report,WRNIP1was found in a number of proteomic screens
aimed at the identiﬁcation of post-translationally modiﬁed proteins. All sites for potential ubiqui-
tylation, SUMOylation, NEDDylation and phosphorylation are depicted in Figure 23A. Addition-
ally, GPS-SUMO prediction algorithm (http://sumosp.biocuckoo.org/) identiﬁed several putative
SUMO-interacting motifs within WRNIP1, marked in the schematic in light brown.
First, in order to conﬁrm the presence of ubiquitylation, Flag-taggedWRNIP1was co-expressed
with HA-tagged ubiquitin in human cells. Western blotting of isolated WRNIP1 clearly showed
that the protein was indeed ubiquitylated in a UBZ-dependent manner (Figure 23B, upper panel).
To identify the modiﬁed residue, several lysine-mutants were generated, chosen based on how
frequent they were found in proteomic studies. All WRNIP1L variants were expressed and iso-
lated from human cells, followed by Western blotting or in-gel staining (Figure 23B, lower panel).
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Figure 23: Post-translational modiﬁcations of WRNIP1. (A) Schematic depicting ubiquitylation (blue
triangles), SUMOylation (yellow triangles), NEDDylation (pink triangle) and phosphorylation (orange tri-
angles below). Predicted SUMO-interacting motifs (SIM) are indicated in light brown in the inset. Modiﬁ-
cations were found on the PhosphoSitePlus database or predicted by GPS-SUMO (SUMOylation and SIM)
and NeddyPreddy (NEDDylation). Generated mutants shown in (B) are marked with red asterikses. (B)
Analysis ofWRNIP1 ubiquitylation. Upper panel -Western blotting analysis of Flag-WRNIP1 isolated from
cells co-expressing Flag-WRNIP1 and HA-Ubiquitin. Lower panel - Western blotting (left) or SDS-PAGE
analysis of indicated mutant Flag-WRNIP1L. Dashed lines indicate excised irrelevant lanes. (C) Analysis of
SUMOylation (upper panel) and NEDDylation (lower panel) of WRNIP1 in cells.
Unfortunately, none of the mutants could recapitulate complete lack of modiﬁcation seen for
the UBZ-mutant (D37A) or any reduction in the amount of modiﬁed protein. In line with the
literature, WRNIP1 was also SUMOylated (Figure 23C, upper). Interestingly, WRNIP1, espe-
cially the long isoform, was also modiﬁed by NEDD8 - another ubiquitin-related peptide (Figure
23C, lower). Interestingly, NEDDylation was detected mainly in the lower band, suggesting that
WRNIP1 could be constitutively modiﬁed in cells.
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DISCUSSION
21 Results discussion
21.1 WRNIP1 protects replication forks after their stress-induced rever-
sal by binding to the resulting 4-way junction
In this project, we aimed at investigating the role ofWRNIP1 in the replication stress response and
elucidating the underlying mechanism. Recently, the protein was found to protect stalled replica-
tion forks fromMRE11-dependent degradation, however the mechanistic data were still missing
(Leuzzi et al., 2016). Here, we employed in vitro analysis of WRNIP1 activity and investigated
further its cellular function, which led us to a model, in which WRNIP1 protects replication forks
after their stress-induced remodeling, by binding speciﬁcally to 4-way junctions that result from
stalled fork reversal (Figure 24).
Figure 24: Proposed model. See text for details
Our proposed model stands in disagreement with published data. The study mentioned above
concluded that stalled replication forks are not reversed prior to MRE11-dependent degradation
in the absence of WRNIP1, since knock-down of RAD51, which should prevent fork reversal, did
not rescue fork protection (Leuzzi et al., 2016). In contrast, we reproducibly saw that fork resec-
tion in WRNIP1-deﬁcient cells can be avoided completely by RAD51 depletion (Figure 21). The
simplest explanation for this discrepancy could be the eﬃciency of RAD51 knockdown, which
in our case was full, while only partial in the case of the other study. RAD51 has a crucial, but
complex, role in replication fork reversal and protection. It was recently shown that the RAD51
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T131P mutant, which cannot form stable nucleoﬁlaments (Wang et al., 2015), is still able to me-
diate fork reversal, but is incapable of fork protection (Mijic et al., 2017). It is therefore plausible
that incomplete RAD51 knockdown would leave enough protein to remodel stalled forks, but not
enough to avoid their over-processing by nucleases. To corroborate our ﬁndings, we have also
blocked replication fork reversal by depleting the fork remodeling ATPases ZRANB3 and HLTF,
both of which were recently shown to prevent fork degradation in a BRCA2-deﬁcient background
(Taglialatela et al. (2017), Mijic et al. (2017)). In the case of WRNIP1-depleted cells, knockdown of
either ZRANB3 or HLTF led to a complete rescue of fork protection (Figure 21), further showing
that WRNIP1 acts downstream of replication fork reversal. These ﬁndings will be next corrobo-
rated by performing a direct visualisation of replication intermediates by electron microscopy, as
was recently done for BRCA2 (Mijic et al., 2017).
In the next steps, it will be interesting to analyse which functional domains of WRNIP1 are
necessary for its protective function. Preliminary data from complementation studies were in-
conclusive, possibly due to the fact that ectopic expression of WRNIP1 leads to an extreme over-
production of the protein, which may be counter-productive due to WRNIP1’s apparent propen-
sity to form stable oligomers, as discussed later.
Surprisingly, preventing stalled fork degradation by RNAi-mediated depletion of MRE11, but
not inhibition by mirin could rescue replication fork stability in WRNIP1-deﬁcient background;
in agreement with literature, mirin fully rescued stalled fork protection in BRCA2-deﬁcient cells
(data not shown). The diﬀerent eﬀect of RNAi-mediated knock-down and inhibition with mirin
could be due to the fact that the inhibitor blocks only the exonuclease activity of MRE11 (?)Shi-
bata2014), leaving the endonuclease activity intact. MRE11 initiates end-resection by nicking
dsDNA away from the end, generating an entry point for its 3’-5’ exonucleolytic activity (Stracker
and Petrini, 2011), it is therefore possible that WRNIP1 prevents nucleolytic degradation of a
stalled replication fork at an early stage, which putatively depends on the endonucleolytic ac-
tivity of MRE11. To validate this hypothesis, we will make use of more available MRE11 inhibitor
PFM01, which speciﬁcally targets the endonuclease activity of the protein (Shibata et al., 2014).
Unexpectedly, even thoughWRNIP1 is needed for stalled fork protection, it is dispensable for
cell survival upon genotoxic treatment (Figure 20A). Evidently, more sensitive assays should be
employed to assess WRNIP1’s importance for the maintenance of genomic stability, e.g. analysis
of chromosomal aberrations by metaphase spreads. Moreover, to our surprise, we were unable to
reproduce the fork degradation phenotype inWRNIP1 knock-out cell lines (Figure 22C). Possibly,
long culturing of the cells, which is required to isolate knock-out clones, led to adaptation of cells
to the absence of WRNIP1. It is known that cells may eventually adapt to unfavourable circum-
stances by, e.g. secondary mutations or upregulation of compensatory pathways. For instance, it
was recently shown that HR-deﬁcient tumours might acquire chemoresistance to PARP inhibitor
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by the loss of PTIP, a factor that normally promotes stalled fork degradation. This leads to stabili-
sation of replication forks in spite of the absence of BRCA2 (Chaudhuri et al., 2016). While we do
not plan on investigating the WRNIP1 knock-out cell lines any further, it is evident that induc-
ing a complete absence of an important factor may dramatically rewire cellular pathways, there-
fore studies involving knock-out cells should be always complementedwith RNAi-based transient
knock-down.
While our initial hypothesis assumed that WRNIP1 could have a direct role in replication fork
remodeling, we did not detect branchmigration, or any DNAmetabolising activity (Figure 17), in-
dicating that WRNIP1 does not actively remodel replication forks. This notion was corroborated
by experiments in cells, where we showed that depletion of WRNIP1 does not inﬂuence repli-
cation fork progression upon replication stress, in contrast to the absence of enzymes involved
in fork regression, such as RAD51 (Zellweger et al., 2015), ZRANB3 (Vujanovic et al., 2017) and
HLTF (Kile et al., 2015).
On the other hand, WRNIP1 shows DNA binding abilities, with a strong preference for 4-way
junctions (Figure 16). This result led us to hypothesise that WRNIP1 may stabilise reversed repli-
cation forks, rather than actively generating them. Interestingly, WRNIP1 decreased the eﬃciency
with which ZRANB3 is able to reverse plasmid-based replication forks in vitro (Figure 19B). The
ﬁrst experiment was done in an end-point fashion, however the assay also allows for monitoring
the extent of fork reversal. It will be therefore interesting to investigate whether WRNIP1 causes
accumulation of forks with regressed arms of speciﬁc length, preventing too extensive reversal.
Also, while so far we only investigated the functional interaction betweenWRNIP1 and ZRANB3,
we will expand our analyses to another fork reversing enzyme – HLTF.
The above observations allow us to speculate that WRNIP1 is an early responder to replica-
tion fork stalling and remodeling. Based on WRNIP1’s DNA binding abilities and preference for
4-way junctions, we propose that the protein binds to replication forks that have been regressed
by the co-operative action of RAD51 and ZRANB3 or HLTF, thus preventing excessive fork rever-
sal and nucleolytic over-processing. A similar model was recently described for the maintenance
of telomere integrity, when TRF2, a component of the Shelterin complex, was found to protect
t-loops against cleavage, by binding to the branch-point at its base (Schmutz et al., 2017).
21.2 Potential mechanism for WRNIP1-BRCA2 epistasis in the protec-
tion of stalled replication forks
WRNIP1 was found to act in the same protective pathway as BRCA2 (Leuzzi et al., 2016). Recent
data suggest that BRCA2 is not necessary for preventing stalled fork degradation at an early time-
point (30 min after fork stalling), but becomes indispensable later (120 min after fork stalling)
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(Lemaçon et al., 2017). Interestingly, WRNIP1’s abundance at replication forks increases rapidly
right after fork stalling, peaks at the 15 min time-point, and then decreases (Dungrawala et al.,
2015). It is therefore plausible that the protein is crucial for preventing nucleolytic degradation
immediately after fork reversal and then "hands over" to BRCA2, which is in turn required for fork
protection when replication stress persists. A time-resolved fork degradation assay will be done
to validate this hypothesis.
21.3 WRNIP1 preferentially binds 4-way DNA junctions and is active as
a monomer or a low-order oligomer
We found that WRNIP1 binds DNA in vitro, with a preference for 4-way junction substrates that
mimic Holliday junctions or reversed replication forks. At ﬁrst, we observed a much broader
substrate speciﬁcity, i.e. WRNIP1 was found to bind to any structure that had a branching point
(Figure 16A). However, we realised that our experimental conditions probably caused unfolding of
the protein by the action of SDS, whichmay have caused either unspeciﬁc protein-DNA complexes
or exposedWRNIP1’s DNA-interaction surface, whichwas otherwise shielded by oligomerisation
or aggregation of the protein. The latter hypothesis is more plausible, since not all DNA substrates
were bound by WRNIP1 and there was a clear preference for a 4-way junction. Indeed, when the
DNA binding assay was performed in native conditions, we observed that only the 4-way junction
was shifted, interestingly only by wild type WRNIP1S and not WRNIP1L (Figure 16B). To deter-
mine whether the ability to bind 4-way junctions was unique to the short isoform, we tested all
other puriﬁedWRNIP1 variants for DNAbinding. Surprisingly, apart from allWRNIP1Smutants,
also K274AWRNIP1L was able to shift the 4-way junction substrate (Figure 16C), suggesting that,
in principle, both isoforms have the same DNA binding ability. To explain this discrepancy, we
analysed all WRNIP1 preparations. Closer examination by the use of native-PAGE coupled to
Western blotting revealed that, apart from the major high MW WRNIP1 population, there is an
additional, much less abundant form of a higher electrophoreticmobility, suggesting a smaller size
(Figure 15E). Interestingly, the latter population was present only in WRNIP1 preparations that
were able to speciﬁcally bind to 4-way junctions (Figure 16C). These results raise the interesting
possibility that WRNIP1, while mostly present in stable higher-order oligomers, binds DNA only
as a monomer or lower-order oligomer.
In 2005, WRNIP1’s size was analysed by gel ﬁltration and glycerol-gradient ultracentrifuga-
tion, and it was determined that the protein assembles into homo-octamers (Tsurimoto et al.,
2005). This notion has never been challenged, since oligomerisation was expected from a protein
belonging to the AAA+ ATPase family. However, members of this family usually form hexameric
rings, with some exceptions, most notably RFC (pentameric) or the apoptosome (heptameric); an
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octameric human AAA+ ATPase has never been reported (rev. in Wendler et al. (2012)). Also, the
authors’ conclusion about the oligomeric state of WRNIP1 is surprising, since their data from
glycerol-gradient ultracentrifugation clearly indicates that the protein sediments faster than alco-
hol dehydrogenase (141-151 kDa), but slower than catalase (232 kDa), and disagrees with their gel
ﬁltration results that showsWRNIP1 eluting at a similar volume as thyroglobulin (669 kDa). Inter-
estingly, fractionation of cell extracts by size-exclusion chromatography revealed that the endoge-
nous WRNIP1 eluted in two populations – one of high MW (600-700 kDa) and another of lower
MW (100-200 kDa) (Crosetto et al. (2008), Tan et al. (2017)). The second study also shows that in the
conditions that activateWRNIP1 the lowerMW complexes becomemore abundant. Interestingly,
such a behaviour has been already reported, e.g. for RAD51, whose oligomers have to be disrupted
to enable loading of the protein onto DNA (rev. in Lord and Ashworth (2007)), or RAD18, which
under unperturbed conditions exists as oligomers/aggregates that are disrupted when the protein
needs to be activated in the response to DNA damage (Zeman et al., 2014). Although data regard-
ingWRNIP1 suggest that the proteinmay follow a similar behaviour, the hypothesis was never put
forward, therefore we plan to investigate it by analysing a non-oligomerising mutant of WRNIP1
and by checking the oligomeric state of WRNIP1 that is bound to chromatin, in a similar manner
as has been recently done for the replisome-associated redox sensor PRDX2 (Somyajit et al., 2017).
As noted, not all of our WRNIP1 preparations contain the lower MW population, i.e. WRNIP1L
WT, D37A and E329Q seem to form exclusively high-order oligomers (Figure 15E). A possible
explanation could be the fact that, according to the predicted structures (Figure 13B), the two
isoforms diﬀer in the folding of the C-terminus, which is reportedly responsible for oligomerisa-
tion of the protein (Crosetto et al., 2008). It is thus possible that WRNIP1S self-associates more
weakly than WRNIP1L. As for the ATP-binding mutant WRNIP1L K274A, it has been observed
that mutations in the ATP-binding pocket of AAA+ ATPases (as is the case for K274Amutant) may
compromise their ability to form oligomers (rev. in Wendler et al. (2012)).
21.4 WRNIP1 interactome
To gain more insight into WRNIP1’s cellular function, we wanted to identify its yet undiscovered
interaction partners. This turned out to be a diﬃcult task since WRNIP1 seemingly did not inter-
act with any protein involved in DNA metabolism or DNA damage response, irrespective of the
strategy we used (diﬀerent tags, IP of endogenous protein, cell fractionation, diﬀerent cell lines).
The only meaningful data was acquired when cross-linking was included in the protocol (Figure
18A). Identiﬁcation of many replisome components indicated that, in our experimental condi-
tions, WRNIP1 does associate with replication forks, which is in line with the literature ((Alabert
et al., 2014), Dungrawala et al. (2015)); we were unable to show WRNIP1’s association with the
Bartlomiej Porebski DISCUSSION
64 21. RESULTS DISCUSSION
replisome by iPOND (data not shown). Interestingly, several proteins involved in the transactions
at stalled replication forks were also found in the dataset, such as MRE11, HLTF, RECQ1, PARP1
or CHD4 (Figure 18B). However, we could not recapitulate any of the interactions by WRNIP-IP
andWestern blotting (Figure 18C). The reason for this could be either the fact that cross-linking is
prone to give false positive results, or the transient and weak nature of WRNIP1 interactions. We
think that the latter is more plausible, since also the reported interactions of WRNIP1 with Polη
(Yoshimura et al., 2014) or ZRANB3 (Ciccia et al., 2012) are either very weak or seen only upon
severe treatment of cells. Also, mass spectrometry or IP approaches never identiﬁed ZRANB3,
although we were able to clearly show the interaction when the two proteins were expressed in a
heterologous system (Figure 18D). Surprisingly, in our mass spectrometry datasets we have never
found WRN, RAD51 or BRCA2, all of which were reported to interact with WRNIP1. In the case
of the interaction with WRN, the analysis was done on puriﬁed proteins (Kawabe et al., 2001),
suggesting that the complex may be too transient to be detected in cell lysates. As for the lack of
interaction with BRCA2 or RAD51, the diﬀerence is hard to explain, since we have tried to reca-
pitulate this result using exactly the same protocol as in the reported study (Leuzzi et al., 2016),
however no interaction was found (data not shown).
Our interactome study suggests thatWRNIP1 does not seem to form stable complexes in cells.
We hypothesised that oneway to explain such an uncommon behaviourwould be ifWRNIP1were
a protein chaperone. Chaperones, that are most commonly oligomeric proteins, bind to their sub-
strates, which triggers ATP hydrolysis and, in turn, remodeling of the interaction partner, followed
by a rapid dissociation of the complex. Many AAA+ ATPases are chaperones, with the most no-
table examples being HSP (Heat Shock Protein) proteins or p97/VCP (rev. in Saibil (2013)). The
latter protein has a well-established role in the DNA damage response, e.g. it was shown to extract
Polη from DNA after TLS (Davis et al., 2012) or Ku70/80 after NHEJ (van den Boom et al., 2016).
Interestingly, p97 is targeted to its polyubiquitylated substrates by adaptor proteins, such as DVC1,
which has a UBZ domain that mediates substrate recognition (Davis et al., 2012). Since WRNIP1
has an AAA+ ATPase domain, reportedly forms oligomers and binds polyubiquitin chains via its
UBZmotif, we hypothesise that itmay have a similar function as p97-DVC1. Apart from the lack of
stable protein-protein interactions, this could also explain the very weak, DNA-independent AT-
Pase activity. To address the latter, we have attempted mass spectrometry analysis using WRNIP1
mutants that are unable to hydrolyse ATP (K274R or E329Q), however it did not improve the re-
sult (data not shown).
An alternative, or complementary, explanation for the limited success of our interactome anal-
ysis could be the aforementioned possibility that WRNIP1 is inactive in its oligomeric state. Since
in most of the experiments we have over-expressed WRNIP1 to extremely high levels, it is plau-
sible that the majority of the protein self-associates and does not engage in protein-protein inter-
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actions. In this view, it would be interesting to check which form of WRNIP1 – high or low MW
– interacts with ZRANB3. The fact that WRNIP1S is reproducibly pulled-down with ZRANB3
more eﬃciently than WRNIP1L, despite being expressed at lower level, suggests that the lowMW
population engages in interactions, however this would need to be conﬁrmed by e.g. native PAGE
of analytical gel ﬁltration. Also, themost recent study shows that, in the conditions promoting for-
mation of a complex betweenWRNIP1, TRIM14 (Tripartitemotif 14) and PPP6C phosphatase, the
low MW (100-200 kDa) population of WRNIP1 is more abundant (Tan et al., 2017).
21.5 Post-translational modiﬁcations of WRNIP1
Lastly, we were interested in elucidating the role of WRNIP1 modiﬁcations for its cellular func-
tion. It is well established that the protein is ubiquitylated in a UBZ-dependent manner (Bish and
Myers, 2007). We were able to recapitulate this result by showing that the WRNIP1 UBZ mutant
(D37A) is not modiﬁed by ubiquitin anymore (Figure 23B). This observation is reminiscent of a
phenomenon called "coupled monoubiquitylation", where the modiﬁcation of a protein depends
on its ubiquitin-binding motif. One model explaining this, proposes that the substrate protein
binds to a ubiquitylated E3 ubiquitin ligase, which enables the modiﬁcation of the substrate pro-
tein (rev. in Haglund and Stenmark (2006)). The co-existence of a UBD and mono-ubiquitylation
can provide an elegant auto-inhibitorymechanism, where an intra-molecular interaction between
the two is formed. Such a negative-feedback loop was described for Polymerase η, which inhibits
its unscheduled interaction with PCNA in unperturbed conditions. On the other hand, when the
TLS pathway has to be initiated, ubiquitylation of Polη is lost and the protein can use its UBD
to interact with PCNA and perform its function (Bienko et al., 2010). Another UBZ-containing
protein, RAD18, was also shown to be mono-ubiquitylated which inhibited its cellular functions
(Zeman et al., 2014). In this case, the authors found that the inhibitory eﬀect was due to the binding
of RAD18-Ub to the unmodiﬁed protein, tethering RAD18 into large, inactive aggregates. Geno-
toxic treatment caused de-ubiquitylation, allowing RAD18 to form functional complexes with its
interaction partners HLTF and SHPRH. Out of the two presented mechanisms, the ﬁrst one seems
to be more plausible forWRNIP1, since theWRNIP1 UBZmutant forms the same highMW com-
plexes as the wild type protein. If the intra-molecular UBD-ubiquitin interaction indeed inhibited
the formation of complexes with interaction partners, preventing ubiquitylation should lead to
the identiﬁcation of more WRNIP1 interactors. This was however not the case – the dataset ob-
tained forWRNIP1D37Awas not signiﬁcantly diﬀerent than the one of thewild type protein (data
not shown). On the other hand, the WRNIP1 UBZ mutant was also over-expressed to extremely
high levels, which may have potentially caused issues, as discussed above. So far, the inability
of WRNIP1 UBZ mutants to localise to sites of DNA damage was explained by a compromised
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recognition of polyubiquitylated PCNA (Crosetto et al. (2008), Nomura et al. (2012), Kanu et al.
(2016)). However, it is also possible that the lack of UBZ-dependent ubiquitylation contributes
to the phenotype. Therefore, we wanted to identify the modiﬁed lysines and generate a WRNIP1
mutant that cannot be ubiquitylated, but still has a functional UBZ domain. Based on available
proteomics data, we have mutated several lysine residues, however none of the mutants could
recapitulate the complete lack of modiﬁcation seen for the UBZ mutant (Figure 23B). This is not
surprising, since it is known that adjacent lysine residues can compensate and get modiﬁed, which
was shown for e.g. Polymeraseη that had to be mutated at 4 sites to abrogate monoubiquitylation
(Bienko et al., 2010). Therefore, we are planning to generate multiple-lysine mutants and anal-
yse the function of unmodiﬁed WRNIP1 in the replication stress response. Interestingly, a recent
study has identiﬁed WRNIP1 as one of less than 100 substrates of the BRCA1 E3 ubiquitin ligase
(Kim et al., 2017). To investigate this further, we plan to check the ubiquitylation status ofWRNIP1
in BRCA1-depleted cells.
As for the other potential modiﬁcations of WRNIP1, namely SUMOylation, NEDDylation
or phosphorylation (Figure 23A), more basic experiments have to be done to conﬁrm their exis-
tence, e.g. de-modiﬁcation of WRNIP1 isolated from human cells with the respective enzymes.
Only then it would be interesting to investigate further to ﬁndmodiﬁed residues and the potential
function of thesemodiﬁcations. The same holds true for the putative SIMs that were found by pre-
diction algorithms. While the high evolutionary conservation of primary sequence is promising,
ﬁrst, the ability of WRNIP1 to bind SUMOmoieties has to be conﬁrmed.
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22 Concluding remarks and outlook
In this study, we have investigated further the role of WRNIP1 in the protection of stalled replica-
tion forks againstMRE11-dependent deleterious over-processing. We have suggested amolecular
mechanism of the protective function, which is unprecedented, despite the ever-growing list of
factors that are necessary to avoid stalled replication fork over-resection. Our in vitro analysis of
WRNIP1’s function and oligomeric state challenges the existing evidence and provides a possible
explanation as to why the characterisation of WRNIP1’s functions and activities has been so dif-
ﬁcult thus far.
On the other hand, our data necessitatesmore experiments to elucidate the function ofWRNIP1
further or to conﬁrm preliminary observations. I believe that the most crucial future experiments
involve:
1. Direct visualisation of replication intermediates – this analysis will be done to validate my
DNA ﬁbre data indicating that in WRNIP1 absence MRE11-dependent degradation targets
reversed replication forks. The analysis will be performed in collaboration with Prof. Mas-
simo Lopes group.
2. Rescue of fork protection by complementation with WRNIP1 alleles – this analysis will
deﬁne which functional domains or features of WRNIP1 are necessary for the protein’s
function in replication fork protection. To do so, conditions where WRNIP1 is expressed
at physiological level have to be established.
3. Epistasis with BRCA2 – to validate our model suggesting that WRNIP1 is needed for fork
protection immediately after replication fork reversal, fork degradation time-course exper-
iments will be done.
4. Puriﬁcation of low MW WRNIP1 – our DNA-binding data and yet-unnoticed published
observations indicate that WRNIP1 may be active as a low-order oligomer or a monomer.
Since it is known that the C-terminal part of the protein is necessary for oligomerisation,
truncations will be introduced in order to force WRNIP1 out of the putatively inactive
oligomers. Such mutants will be analysed in vitro for DNA binding and for inﬂuence on
replication fork reversal.
5. WRNIP1’s inﬂuence on replication fork reversal in vitro – ﬁrst, the initial data suggesting
that WRNIP1 inhibits ZRANB3’s fork reversal activity will be conﬁrmed. Then, a more
detailed analysis of the extent of reversal in the presence ofWRNIP1will be done to validate
our hypothesis that WRNIP1 binds to early-stage reversed forks. Finally, the same analysis
will be done with HLTF.
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6. Oligomerisation status of WRNIP1 in cells – to validate our hypothesis about WRNIP1 be-
ing active as amonomer or a low-order oligomer, the oligomeric status of the proteinwill be
checked by analytical size-exclusion chromatography or native-PAGE of subcellular frac-
tions and/or in response to genotoxic treatment.
7. Modiﬁcation of WRNIP1 - WRNIP1 seems to be a heavily modiﬁed protein, therefore a
comprehensive study of its PTMs is impossible within the scope of this project. However,
since WRNIP1 is a putative substrate for BRCA1, I believe that it would be interesting to
follow this lead and check whether or not WRNIP1’s function depends on this important
tumour suppresor.
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